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Abstract 
Nucleoprotein (NP) of influenza A has been found not just contributing to the major 
structural framework of ribonucleoprotein (RNP) particles by homo-oligomerization, 
but also performing multiple essential functions for mediating the 
transcription-replication process of the viral genome； particularly in the modulation 
of nucleocytoplasmic trafficking of RNP complexes. 
Here, by RNP reconstitution assay； eight NP mutants were identified which had 
different degrees of defect in forming functional RNPs, with the RNP activity offour 
mutants totally abolished (E339A; V408S,P410S; R416A; L418S,P419S) and the other 
four more than 50% decreased (R267A; I406S, R422A; E449A). Static light scattering 
showed that the variants existed in different defective oligomeric states, suggesting 
the decrease of RNP activity was caused by the defect of NP to form oligomer. The 
data propose three factors for NP oligomerization event: (1) interaction between the 
tail loop and the insertion groove; (2) maintenance of the tail loop conformation; 
and (3) stabilization of NP homo-oligomer. 
Another part of the study concerns nuclear import of NP. Two nuclear localization 
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signals (NLS): NLS1 (aa. 3-13) and NLS2 (aa. 198-216), have been found in NP. Here, 
NLS1, not NLS2, was shown to be important for binding to importin a5, which is 
consistent with the previous findings of its dominant role for the nuclear import of 
RNP and NP. Surprisingly, using surface plasmon resonance, NLS2 bound stronger 
than NLS1 to a5. Masking of NLS2 by RNA or the oligomerization of NP in the cytosol 
may weaken the influence of NLS2 on nuclear import. Further characterization by 
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Chapter 1 Introduction 
The recent outbreak of 2009 H1N1 influenza pandemic has so far caused more than 
eighteen thousands people deaths worldwide over 214 countries, oversea territories 
and communities (World Health Organization, 2010). Albeit its low lethality, H1N1 
raises the concern of the way to prevent potential influenza pandemic which may 
be caused by strains of higher pathogenicity and virulence. Besides the new H1N1 
strain, another more virulent strain is H5N1, which has mortality rate of (up to May 
of 2010) 60% (World Health Organization, 2010). Since the first 
human confirmed case of Avian Flu H5N1 in Hong Kong in 1997, and recurrent 
reported cases in nearby countries； H5N1 is still regarded as the marked subtype of 
influenza A that may cause the next upcoming pandemic (Webster et al., 2006). 
However, there is still no highly effective treatment of H5N1 flu. Therefore, the 
work of pandemic planning brooks no further delay. 
A candidate of influenza A viral protein is Nucleoprotein (NP), which is found not 
just contributing to the major structural framework of ribonucleoprotein (RNP) 
particles by homo-oligomerization, but also performing multiple essential functions 
for mediating the transcription-replication process of the viral genome, particularly 
in the modulation of nucleocytoplasmic trafficking of RNP complexes. Further 
13 
understanding the multifunctional role of NP would lay the foundation of anti-viral 
drug development. 
L1 The Severity of Influenza A Virus 
Influenza is a contagious respiratory disease causing annual epidemics 
and occasional pandemics. There are two flu seasons each year and the total 
death toll of an annual epidemic can vary between 300,000 to 500,000 worldwide 
(Harper et al., 2005). In contrast to these regular seasonal epidemics, outbreak of 
an irregular pandemic can be highly deadly. In the last 400 years, at least 31 
influenza pandemics have been recorded {Lazzari et al., 2004). For instance, the 
"Spanish Flu", caused by a H1N1 subtype in 1918, killed 50 to 100 million people 
worldwide (Johnson and Mueller, 2002). In 1997, a bird-adapted strain of influenza 
A H5N1 outbreak resulted in six deaths among 18 cases in Hong Kong, with a high 
mortality rate of 33 % (Yuen et al., 1998). Since then, avian flu has become the 
major threat of the next pandemic (Normile, 2006), though the recent pandemic in 
2009 was caused by reassorted viruses combined of human, bird and pig viral strains. 
Starting from 2003, the poultry-to-human transmission of the virus has been 
reported from 10 countries in Asia and Africa from year to year. Until 6 May 2008, 
there are a total of 498 laboratory-confirmed human cases in which 294 are fatal 
14 
(World Heath Organization, 2010). To combat the virus, it is crucial to have a 
better understanding on how influenza virus, in particular H5N1, organizes 
and functions. 
1.2 Introduction to Influenza A Virus 
Influenza A virus belongs to the family Orthomyxovirdae. It is an enveloped, 
negative-stranded RNA virus. Influenza A virus has a genome comprising of eight 
negative-sense RNA segments, which encode several identified proteins, including 
haemagglutinin (HA), neuraminidase (NA), matrix protein Ml, ion channel M2, 
non-structural proteins NS1 and NS2, nucleoprotein (NP), pro-apoptotic protein 
PBl-F2 and RNA polymerase PA, PB1 and PB2 (Portela and Digard, 2002). 
Influenza virus replicates in the epithelial cells of upper respiratory tract. Sialic 
acid sugars on the cell membrane function as receptor for the glycoprotein HA of 
influenza virus. Influenza A virus enters the cell by clathrin-dependent endocytotic 
pathway. Low pH in endosomes triggers the fusion of viral and endosomal 
membrane, causing the release of viral RNPs into the cytoplasm, lmportins then 
bind to the nuclear localization signals (NLS) present on the RNPs and direct them 
into the nucleus. Primary messenger RNA {mRNA) is synthesized by the viral RNA 
15 
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polymerase complex, followed by the transport to cytoplasm and translation into 
viral proteins. The newly synthesized polymerase proteins and NP are 
translocated into the nucleus； where they initiate the synthesis of complementary 
RNA (cRNA), followed by the new vRNA. The newly synthesized vRNA acts as the 
template for secondary mRNA synthesis, and subsequently viral structural proteins 
(Lamb & Krug, 1996). Polymerase proteins and NP synthesized in the cytoplasm 
are then transported back to nucleus, where they assemble with vRNA to form viral 
RNP. M l and NS2 proteins are also transported into nucleus to mediate the 
nuclear export of newly synthesized viral RNP (Gomez-Puertas et al.； 2000; Lamb & 
Krug； 1996). Finally, new viral progenies bud out from the infected cells with the 
help of NA (Portela and Digard, 2002). 
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Figure 1.1 Replication cycle of Influenza virus, (modified from 
http://www.mpi-magdeburg.mpg.de) 
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Because the lack of a proofreading activity, the RNA-dependent RNA transcriptase 
has been logically assumed as a highly error-prone polymerase which provides the 
genomic mutations to create antigenic drift necessary for viral evolution and host 
adaptation. However； recent findings suggested the RNA transcriptase may be of 
high fidelity, which is important to counter-balance the multiple rounds of genome 
amplification per infection cycle, and as the enzyme has ample opportunities to 
generate and amplify genomic founder mutations to achieve optimal viral 
mutagenesis (Aggarwal et al., 2010). The new virus strains may not be recognized by 
antibodies against earlier strains and therefore, people can be repeatedly 
infected with influenza viruses. 
Antigenic shift is another mechanism which allows influenza to be an ever-changing 
virus. When more than one strains of virus infect a cell, the eight vRNA segments 
reassort. This enhances the chance of generating a new influenza subtype that 
may escape the immune system of the host, resulting in pandemics (Hilleman, 
2002). 
1.3 What is Nucleoprotein ？ 
NP is regarded as one of the most important viral proteins in influenza virus. It is a 
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basic protein {pl>9) with 498 amino acids and molecular weight of 56 kDa. It was 
found to be well-conserved among different influenza A subtypes (Shu et al.； 1993). 
NP is the major component of the ribonucleoprotein (RNP), which is 
a complex consisting of RNA, NP and RNA polymerase. The eight RNPs are 
organized in a unique pattern in the virus with seven ofthem surrounding a central 
RNP (Noda et al., 2006). Since it was proposed that each RNP segment contains a 
specific incorporation signal (Liang et al., 2005), the unique pattern of RNP was 
suggested to be crucial for the selective RNP incorporation to new viral progeny so 
as to maintain the integrity of the viral genome during repeated cycles of 
replication. 
NP is thought to be a switch between transcription and replication. Various 
studies have suggested that RNP or polymerase alone can result in mRNA 
transcription (Skorko et al., 1991; Seong et al., 1992) while non-RNP 
associated (soluble) NP is crucial for positive-polarity RNA (cRNA) and virion RNA 
(vRNA) synthesis (Beaton and Krug, 1986; Shapiro and Krug, 1988). Three 
hypotheses were proposed on how soluble NP supports cRNA and vRNA synthesis. 
The encapsidation hypothesis proposed that NP is a co-factor 
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to co-transcriptionally coat the newly-synthesized cRNA (Shapiro and Krug, 1988). 
The template modification hypothesis suggested that the structure of RNA template 
is altered by its interaction with soluble NP, thus changing the mode of RNA 
synthesis (Hsu et al., 1987; Fodor et al., 1994; Klumpp et al., 1997). The 
polymerase modification hypothesis held that interaction between NP 
and polymerase subunits PB1 and PB2 changes the transcriptional activity of the 
polymerase (Biswas et al., 1998; Mena et al., 1999). 
lAMultifunct1onal roles ofNucleoprotein 
1.4.1 Interaction of Nucleoprotein with Other Viral Components 
(i) NP-RNA binding: The RNA binding domain was suggested from the first 
nucleoprotein crystal structure (Ye et al., 2006). Latter it was finely mapped to 
the protruding element (residues 167-186) situated at a spacious groove 
between the head and body domains. Many positively charged residues in the 
protrusion and nearby regions were found to contribute RNA binding, in 
particular R74, R75, R174, R175 and R221 (Ng et al., 2008). 
19 
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Figure 1.2 Crystal structure of NP. (A) Electrostatic potential distribution for 
H1N1 NP identifies a potential RNA-binding site. {B) In H5N1 NP, 
regions containing clusters of arginine residues are denoted as NP-G1 to 
NP-G4. Mutation ofthe arginines in NP-G1 and NP-G2 (magenta) resulted in a 
significant reduction in RNA binding； whereas mutation of the arginines in 
NP-G3 and NP-G4 (green) showed little effect. (Adopted from Ye et al., 2006 
and Ng et al., 2008) 
(ii) NP-NP oligomerization: NP forms homo-oligomers to maintain a higher order 
structure of RNP (Prokudina-Kantorovich and Semenova, 1996; Elton et al.； 
1999). Crystal structure of trimeric NP revealed the NP protomers 
were connected by insertion of long tail loop from one NP protomer into the 
body domain of a neighboring protomer (Ye et al.； 2006; Ng et al., 2008). 
Comparing both NP structure； it was suggested the flexibility of two linkers 
(residues 397-401 and 429-437) is important for NP to form higher-order 
oligomers during virus packaging (Ng et al.； 2008). 
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Figure 1.3 H5N1 NP and H1N1 NP have identical interactions ofthe tail loops 
but form different trimers. (A) Superimposition of one molecule ofthe H5N1 
NP trimer (in color) with a molecule of the H1N1 NP trimer (gray) shows that 
the other two molecules do not superimpose with each other. Nevertheless； 
the interaction of the tail loop of one NP molecule with the neighboring 
protomer in H5N1 {B) and H1N1 (C) is virtually identical. (Adopted from Ng et 
al., 2008) 
(i i i) NP-polymerase interaction: The low resolution structure of recombinant RNP 
reveals two contact points between NP and the polymerase complex 
(Martin-Benito et al., 2001). In agreement with this； NP is shown to interact 
with polymerase subunits PB1 and PB2 but not PA by immunoprecipitation 
(Biswas et al" 1998). Such interaction may be important for the RNP 
formation and it is also hypothesized that this interaction has a regulatory role 
towards the polymerase activity (Biswas et al., 1998; Mena et al., 1999). 
Recent finding suggested that a direct interaction of NP and polymerase 
results in a modification of polymerase in favor of unprimed initiation 
(Newcomb et al., 2009). 
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1.4.2 Interaction of Nucleoprotein with Cellular Components 
(i) NP-importin-a interaction: There are two recognized nuclear localization 
signals (NLS) in NP. The N-terminal 1-20 amino acids were found to be a 
transferable NLS in mammalian cells (Wang et al., 1997). A bipartite NLS (aa 
198-216) had also been identified afterwards (Weber et al., 1998). Both NLS 
are found to interact with importin-a, but they act differently in mediating 
nuclear accumulation of NP (Ozawa et al., 2007). 
(ii) NP-F-actin binding: At the late stage of viral infection, NP localizes in 
the cytoplasm and it was found to be mediated by interaction between NP 
and F-actin with binding ratio of 1:1. Mutations within or around the 
previously wrongly-determined oocyte NLS {aa 327-345) were found to disrupt 
the interaction between the two. These sites and the oocyte NLS were 
defined as cytoplasmic retention signals (Digard et al., 1999). 
(iii) NP-CRM1 interaction: It has been observed that NP 
biased towards cytoplasmic accumulation when CRMVexportin-1 was 
inactivated by drug application {Elton et al., 2001), suggesting interaction 
between NP and CRM1 mediates the nuclear export of NP. The nuclear 
export signal {NES) of NP has been proposed to localize at the N-terminal 1-38 
amino acids (Neumann et al., 1997); but more evidence is needed to confirm 
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this hypothesis. Nonetheless, the CRMl-NP interaction did not induce the 
hydrolysis of GTP by Ran in the presence of RanGAP, suggesting the interaction 
may not lead to nuclear export (Akarsu et al., 2003). 
(iv) NP'BATl/UAP56 interaction: The N-terminal 1-20 of NP was also found to 
bind a cellular splicing factor； which belongs to some RNA-dependent ATPases 
with DEAD-box (Momose et al., 2001). This interaction was thought to 
stimulate influenza virus RNA synthesis. 
(v) NP-NF90 interaction: A direct interaction of NP and nuclear factor 90, 
independent of other subunit of RNP and RNA, was shown to down-regulate 
both viral genome replication and mRNA transcription in infected cell during 
the early phase of infection. This interaction requires the presence of 
C-terminal part of NP (Wang et al., 2009) 
1.5Aims ofstudy 
The aims of this study are: (1) to identify critical amino acids involved in NP-NP 
oligomerization and (2) to characterize the interaction between NP 
and importin-a. By knowing more about different functional characteristics of 
NP, we hope to lay the foundation for novel therapeutic drug design that may 
perturb influenza virus replication. Since NP is a well-conserved protein, the 
23 
inhibitor may also be used to target other influenza A virus. 
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Chapter 2 Materials and Methods 
2.1Materials 
2.1.1 Chemical Reagents 
The chemical reagents used are listed in Table 2.1. 
Table 2.1 - List of chemicals used 
Formula 
Chemical Reagents Source 色 Weight 
2-mercaptoethanol (P-ME) 冗 ^ Sigma, 
(C2H6OS) . USA 
Acrylamide / Bis-acrylamide; , Sigma, 
30% solution, mix solution 37.5:1 USA 
Acrylamide / Bis-acrylamide; , Amresco, 
40% solution, mix solution 19:1 USA 
A ^ / Sigma, 
Agarose powder / U$A 




Ampicillin, Sodium Salt 371.4 
^ USA 
Perkin Elmer, 
ATP, [y-32P]- lOCi/mmol 2mCi/ml，500 i^Ci 507.18 
^ ” USA 
Bromophenol Blue Sigma, 
(C19H9Br4O5SNa) • USA 
Boric acid 61.83 ^ '^^^ ' 
USA 
3-[(3-Cholamidopropyl)dimethylammonio]-l -propanesulfon USB, 
614.88 
ate (CHAPS) .USA 
Chloramphenicol Sigma, 
(C11H12Cl2N2O5) . USA 




Commassie Brilliant Blue USB, 
826.0 
(C45H44N5O7S2Na) U S A 
Novagen, 
Deoxynucloetides (dNTP) / 
Germany 
USB, 
^ 154.25 U S A 
Sigma, 
1 -ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC) 191.7 
U oA 
Ethanol Merck, 





Ethidium Bromide (EtBr) 394.0 
U oA 
Ethylenediaminetetraacetic Acid (EDTA) 292 2 Sigma, 
(C10Hi6N2O8) . USA 
Formamide, minimum 99% GC Sigma, 
45.04 邑 
(CH3NO) USA 














Iodoacetamide (IAA) 184.0 
Germany 
Isopropanol BDH, 
((CH3)2CHOH) 60.1 England 
. ,^ Invitrogen, 
Kanamycin, sulfate 582.58 
_ _ _ J -USA 
USB, 
LB agar / 
^ USA 
LB broth / 腦 ， 
USA 
2 6 
Methanol ^^ 1 Merck, 
(CH3OH) ‘ Germany 




N-hydroxysuccinimide (NHS) 115.09 
U oA 
Phenylmethyl-sulfonyl Fluoride (PMSF) ^^^ ^ Sigma, 
(C7H7FO2S) ‘ USA 
Bio-Rad, 
Post-stained SDS-PAGE Standards (low range) / , ,^ • 
USA 
Potassium Chloride „ , , USB, 
74.6 
(KC1) USA 
Potassium Phosphate ^^^ ^ Sigma, 
(KH2PO4) • ‘ USA 
Sodium acetate (NaAc) ^^ ^^ Sigma, 
(CH3COONa) ‘ USA 
Sodium Chloride ^ ^ ^ USB, 
(NaCn ‘ USA 
Sodium Dodecyl Sulfate (SDS) USB, 
(CH3(CH2)11SO4Na) . USA 
Sodium Hydrogen Phosphate Sigma, 
(Na2HPO4) . USA 
Sodium Hydroxide ^^ ^ Sigma, 











Triton X-100 / ^ 
USA 










~ ~ u ^ “ “ 
Xylene Cyanol FF 538.61 
USA 
2.1.2 Buffers 
2.1.2.1 Preparation of Buffers 
Buffer was prepared by dissolving chemicals in distilled water (dH2O) 
and calibrated to suitable pH using either HC1 or NaOH, unless otherwise specified. 
2.1.2.2 Buffers for Common Use 
1. 50X TAE buffer stock was prepared with 2 M Tris-acetate and 50 mM EDTA 
and stored at room temperature. 
2. 10X TBE buffer stock was prepared with dissolving 890mM Tris, 890mM 
Boric acid and 20mM EDTA, calibrated to pH 8.3. 
3. 6X DNA loading buffer was prepared with 0.25% (w/v) bromophenol blue, 
40% (w/v) sucrose and 0.25% (w/v) xylene cyanol FF. The buffer was 
stored at 4 °C. 
4. Formamide loading buffer was prepared with mixing 9mL 
deionized formamide, lmL 100mM EDTA and 0.25% (w/v) xylene cyanol FF 
and 0.25% (w/v) bromophenol blue. 
5. lL M9ZB medium was prepared by 1 g NH4Cl, 3 g KH2PO4, 5 g NaCl, 6 g 
Na2HPO4H 2O, 10 g tryptone. After sterilization by autoclaving, 10 ml o f 4 0 
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% glucose (1.25% w/v) and 1 ml of 1 M MgSO4 were added. 
6. Sonication buffer 1 was prepared using 20 mM sodium phosphate, 100 mM 
NaCl, 1 mM EDTA and calibrated to pH 7.0. Before use, PMSF and p_ME 
were added to final concentrations of 1 mM and 10 mM respectively. 
7. Sonication buffer 2 was prepared by using 20 mM Hepes, 500 mM NaCl, 1 
mM MgCl2, 5 mM imidazole, 20 mM p-ME and calibrated to pH 7.0. Before 
use, PMSF was added to final concentrations of 1 mM. 
8. SDS running buffer was prepared using 25 mM Tris base, 192 mM glycine 
and 0.1%(w/v) SDS. 
9. 6X SDS loading buffer was prepared using 12% (w/v) SDS, 375 mM Tris-HCl, 
60% (v/v) glycerol and 0.01% bromophenol blue, calibrated to pH 6.8. The 
buffer was supplemented with 5% (v/v) P-ME and was stored at 4 °C. 
10. Commassie brilliant blue staining solution was prepared with acetic acid, 
methanol and dH2O mixed in a ratio of 1:3:10. 0.05% (w/v) commassie 
brilliant blue was then added. 
11. De-stain solution was prepared with 40% (v/v) methanol and 10% (v/v) acetic 
acid. 
12. Purification buffer Al was prepared using 20 mM sodium phosphate, 100 mM 
NaCl, 1 mM EDTA, calibrated to pH 7.0. 
13. Purification Buffer A2 was prepared using 20 mM sodium phosphate, 100 mM 
29 
NaCl, 20 mM maltose, calibrated to pH 7.0. 
14. Purification Buffer B1 was prepared using 20 mM sodium phosphate, 100 mM 
NaCl, calibrated to pH 7.0. 
15. Purification Buffer B2 was prepared using 20 mM sodium phosphate, 1.5 M 
NaCl, calibrated to pH 7.0. 
16. Purification Buffer C1 was prepared by using 20 mM Hepes, 500 mM NaCl, 1 
mM MgCb, 5 mM imidazole, 20 mM p-ME, calibrated to pH 7.0. 
17. Purification Buffer C2 was prepared by using 20 mM Hepes, 1 M NaCl, 1 mM 
MgCb, 25 mM imidazole, 20 mM P-ME, calibrated to pH 7.0. 
18. Purification Buffer C3 was prepared by using 20 mM Hepes, 500 mM NaCl, 1 
mM MgCb, 1 M imidazole, 20 mM P-ME, calibrated to pH 7.0. 
19. Gel filtration Buffer was prepared by using 20 mM Tris-HCl, 200 mM NaCl, 2 
mM DTT, calibrated to pH 8.0. The buffer was filtered through a 0.22 ^m 
filter cup. 
20. Exchange Buffer was prepared by using 20 mM Tris-HCl, 100 mM NaCl, 2 
mM DTT, calibrated to pH 8.0. 
21. Light Scattering running buffer 1 was prepared by using 20 mM Tris-HCl, 
200 mM NaCl, 2 mM DTT, calibrated to pH 8.0. The buffer was 
filtered through a 0.1 ,^m filter cup. 
22. Light Scattering running buffer 2 was prepared by using 20 mM sodium 
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phosphate, 150 mM NaCl, calibrated to pH 8.0. The buffer was 
filtered through a 0.1 i^m filter cup. 
23. BIAcore immobilization running buffer was prepared by using 20 mM Hepes, 
100 mM NaCl, 0.005 % Tween-20, calibrated to pH 7. 
24. BIAcore running buffer was prepared by using 20 mM Tris-HCl, 150 mM 
NaCl, 2 mM DTT, 5 % glycerol, 0.005 % Tween-20, calibrated to pH 8.0. 
25. Transfer buffer was prepared by using 25mM Tris, 192mM glycine and 10% 
methanol. 
26. Co-immunoprecipitation buffer (co-IP buffer) was prepared by 50mM Tris, 
150mM NaCl and lmM EDTA, calibrated to pH 7.6. 
27. Tris-buffer-saline Tween-20 (TBST) was prepared by 25mM Tris, 150mM 
NaCl and 2mM KC1, calibrated to pH 7.4. 
2.1.3 Plasmids and Strains 
Plasmids pcDNA-PBl, pcDNA-PB2, pcDNA-PA, pcDNA-NP and pPOLI-NA-RT 
were gifts from Dr. Ervin Foder, University of Oxford. 
To clone NP mutants, plasmid pRHisMBP-NP was used as the original template for 
Polymerase Chain Reaction (PCR) reaction. The genes of different mutants are 
inserted to pRHisMBP, pcDNA3 (Invitrogen) and pcDNA3.1/myc-His (Invitrogen) 
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accordingly. 
The PA gene was amplified from pcDNA-PA and cloned into pcDNA3.1 /myc-His. 
To clone full-length and N-terminal truncated mutants of importin-al, 3 and 5, 
plasmids bearing the respective genes (pImportin-al, pImportin-a3 and pImportin-a5) 
were purchased from Harvard Institutes ofProteomics and used as template for PCR 
reaction. The genes of importins were inserted into pRSET vector. 
Escherichia coli {E. coli) strain DH5a was used for plasmid DNA amplification. 
E. coli strain C41 was used for expression ofMBP-tagged NP and its mutants while 
E. coli strain BL21(DE3)pLysS was used for full-length and N-terminal 
truncated importin-al, 3 and 5 expression. 
l,lMethods 
2.2.1 Molecular cloning 
2.2.1.1 Cl0nin2 of tar2et 2enes bv PCR 
By PCR, genes of 17 NP oligo-mutants and 6 NP NLS-mutants were 
generated based on the original template plasmid pRHisMBP-NP. For full-length 
and N-terminal truncated importin-al, 3 and 5，they were cloned from the plasmids 
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pImportin-al, pImportin-a3 and pImportin-a5 respectively. Different pairs of 
primers were designed to anneal to the DNA template. The primers acted in a 
forward (5' to 3’ with respect to the reading frame) and reverse (3' to 5，with respect 
to the reading frame) pair. The primers had GC content of around 50% and there 
was no self-complementation between the primer pair. Information of the primers 





































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Two-step overlapping PCR was performed to amplify all NP-oligo point(s) mutants, 
NP-NLS2mut and NP-ANLSl;NLS2mut DNA, while only one round of PCR was 
needed to amplify genes of NP-ANLS1, full-length and truncated form of 
importin-al, importin-a3 and importin-a5. Composition of reaction mixture and the 
general reaction scheme ofPCR are listed in Tables 2.3 and 2.4 respectively. 
The reactions were carried out by KOD DNA polymerase (Novagen, Germany) in 
PCR tubes in a MJ PTC-100, where lid heating was available. The resulting DNA 
products were analyzed by agarose gel electrophoresis or stored at -20°C. 
Table 2.3 - PCR reaction mixture (IX) 
One-step /~~1'1 2"^ round PCR 
round PCR 
Distilled water 39 i^l 36 ^1 
10X KOD buffer 5 i^l ~5~ \^ 
lOmM dNTPs 2 ^1 2^il 
(2.5 mM each ofdATP, dCTP, dGTP and dTTP) 
Forward primer (25 ^M) 1 _^1 1 ^ 1 
Reverse primer (25 ^M) 1 p.1 1 p,l 
DNA Template - Plasmid 1 ,^1 ---
- ist round PCR product — 4 i^l 
KOD DNApolymerase (5 U/^il) 1 i^l T j l ] 
Total ^ 50 i^l 
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Table 2.4 一 PCR cycles 
Temperature Time Number 
of cycles 
Initial denaturation 95 °C 5 min ---
Denaturation 95 ®C 30 sec 35 
Thermal cycle Annealing 50 °C 30 sec 
Elongation “ 72 "C 2min 
Final extension 72 °C 10 min ---
M 4 � C 一 « ^ 
2.2.1.2 Agarose Gel Electrophoresis 
1.0 % (w/v) agarose gel was prepared by dissolving 0.3 g agar in 30 ml IX TAE 
buffer, with 1 ^1 of ethidium bromide added. PCR products were mixed with 6X 
loading buffer to give a final concentration of IX. The gel was submerged into a 
gel tank containing IX TAE buffer. After loading the samples and Gene Ruler™ 
DNA Ladder Mix (Invitrogen, USA) into the wells, electrophoresis was performed in 
a constant voltage of 100 V. After electrophoresis, the agarose gel was placed onto 
a Spectroline model TC-302 transilluminator (302 nm) for visualization of DNA in 
the gel. Polaroid MP-4 instant camera and Polaroid 667 instant file through a 
HOYA R (25A) red filter were employed to take gel photos. 
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2.2.1.3 Extraction and Purification of DNA from A2ar0se Gels 
The steps were modified from the manufacturer instructions (GeneClean III Kit, Bio 
Lab 101 Inc.). Desired DNA fragment was excised from the gel under the 
illumination of a Sepctroline UV transilluminator. 500 i^l of GEX buffer was 
added to the eppendorf tube containing the gel slice. The mixture was incubated in 
60 °C for about 10 min until the gel was completely dissolved. A column was 
placed onto a collection tube and a maximum of 700 i^l of gel mixture was loaded 
onto the column. T h e column was then centrifuged at 13,000 rpm by desktop 
centrifuge (Minispin, Eppendorf) for 30 s. The flow-through was discarded. T he 
procedures were repeated for the rest of the gel mixture. Next, the column was 
washed with 500 i^l o f W F buffer and then centriftiged at 13,000 rpm for 30 s. The 
flow-through was discarded. After that, the column was washed with 700 ^1 o f W S 
buffer, which contained ethanol’ and then centrifuged at 13,000 rpm for 30 s. 
Flow-through was discarded. As any residual ethanol could affect the quality of 
DNA and inhibit subsequent enzymatic reactions, the column was 
further centrifuged for 3 min to ensure all residual ethanol was removed. After that, 
the column was placed onto a new eppendorf tube and 30 ^1 of warm water was 
added. It was allowed to stand at room temperature for 2 min. DNA was then 
eluted through centrifugation at 13,000 rpm for 2 min. DNA eluted was used for 
the next step or stored at -20�C. 
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2.2.1.4 Restriction Disestion of DNA 
By directional cloning, the DNA fragments obtained by Gene Clean and the 
pcDNA3a, pRHisMBP, pcDNA3.1cMyc, pRSET and pCMV-Tag 2B vector were 
digested respectively by two different restriction enzymes at 37 °C for 2 hours. 
Detailed conditions for restriction digestion are listed in Table 2.5. 
After digestion, 6X DNA loading dye was added to stop the reaction and the reaction 
mixture was analyzed by agarose gel electrophoresis as described in section 2.2.1.2. 
Desired DNA fragment was extracted and purified from the gel by GeneClean III kit 
as described in section 2.2.1.3 for subsequent ligation. 
Table 2.5 - Restriction enzyme digestion mixture 
Vector Insert 
dH2O 12)xl 作1 
Uncut vector / insert 5 ^1 30 fxl 
10X Reaction buffer 
2 d^ 4 Lil 
(New England BioLabs Inc.) 
^coRI/BamHI 
(10 U, New England BioLabs Inc.) ^'^ ^ 1 ^' 
HindIII/Xhol 
(10 U, New England BioLabs Inc.) ^'^ ^^ ^ … 
T ^ 2 ^ 40 i^l 
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2.2.1.5 Lisation of disested insert and expression vector 
The digested insert and vector retrieved from the gel were ligated at correct reading 
frame by T4 DNA ligase in a 20 ^1 reaction mixture at 16 °C for 16 hours. The 
digested insert and vector were mixed in a molar ratio of about 3:1. 
Detailed reaction conditions are listed in Table 2.6. 
Table 2.6 - Ligation mixture 
1 OX T4 ligase buffer (New England BioLabs Inc.) 2 i^l 
Linearized vector 5 ,^1 
Digested DNA insert 12 ^1 
T4 DNA ligase (40 U/^il, New England BioLabs Inc.) 1 ^ 1 
Total 20 i^l 
2.2.1.6 Transformation and platins out transformants for Miniprep 
Different ligation products were individually transformed into freshly thawed E. coli 
strain DH5a competent cells for plasmid amplification. 5 i^l of ligation product 
was added to the eppendorf tube containing 100 |xl of competent cells 
and incubated on ice for 30 min. After that, it was incubated at 42 °C for heat shock 
for exactly 1.5 min, and then kept on ice for 10 min. 500 i^l of LB medium was 
then added, and the cells were incubated at 37 °C for 45 min with constant shaking at 
250 rpm for recovery. The cells were then centrifuged at 13,000 rpm for 30 s. 
Supernatant was discarded and cell pellet was resuspended in 100 i^l o f L B medium. 
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The resuspended cells were then spread evenly onto each LB agar plate containing 
100 ^g/ml of ampicillin or 50 ^g/ml of kanamycin. The plates were incubated at 
3 7 ' C f o r l 6 h o u r s . 
2.2.1.7 Clone checkins bv PCR 
10 single colonies on each plate were selected. One of the 10 
selected single colonies was picked by a toothpick. The toothpick was soaked into 
the PCR mixture to dispense the colony. For the other nine colonies, the same 
procedures were repeated. After that, PCR was performed. The composition of 
PCR reaction mixture and the PCR reaction scheme are listed in Table 2.7 and 2.8 
respectively. PCR products were then analyzed by agarose gel electrophoresis for 
size checking. 
Table 2.7 - PCR reaction mixture for clone checking 
dH2O 15.5 i^l 
10X Reaction buffer 2 i^l 
lOmM dNTPs 1 ^1 
(2.5mM each ofdATP, dCTP, dGTP and dTTP) 
Forward primer (25 ^iM) 0.5 i^l 
Reverse primer (25 ^M) 0.5 i^I 
Tag DNA polymerase (5 U/^il) 0.5 i^l 
Total 20 i^l 
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Table 2.8 - PCR cycles for clone checking 
Temperature Time Number 
of cycles 
Initial denaturation 9 5 � C 5 min ---
Thermal cycle Denaturation 95 °C 30 sec 20 
Annealing 50 ®C 30 sec 
Elongation 72 "C 2min 
Final extension 72 °C 10 min ---
M 4^ ~ — 
2.2.1.8 Minipreparation of Plasmid DNA 
Single positive clone checked was picked and inoculated into 5 ml of LB 
medium containing 100 ^g/ml of ampicillin or 50 ^.g/ml of kanamycin 
and incubated at 37 °C for 16 hours with constant shaking at 250 rpm. Steps of 
plasmid extraction were modified from the manual provided by the manufacturer 
(Wizard Plus SV Minipreps DNA Purification Kit, Promega). First, overnight 
bacterial culture was centrifuged at 13,000 rpm (Minispin, Eppendorf) for 30 s. 
Supernatant was discarded. 250 ^1 o f M X l buffer was added to resuspend the cell 
pellet. 250 i^l o fMX2 buffer was then added and the tubes were inverted gently for 
several times to lyse the cells until the lysate became clear. The mixture was 
incubated at room temperature for 5 min. After that, 350 ^1 of MX3 was added. 
The mixtures were mixed immediately by inversion for several times to neutralize 
the lysate until white precipitates formed. The resulting lysate was centrifuged at 
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13,000 rpm for 10 min. After centrifiigation, supernatant was transferred to a 
DNA-binding column sitting in the collection tube, and centrifuged at 13,000 rpm for 
30 s. Flow-through was discarded. After that, 500 |xl of WF buffer was 
added and centrifuged at 13000 rpm for 30 s to wash the column. Flow-through 
was discarded. 700 \i\ o f W S buffer was then added and centrifuged at 13,000 rpm 
for 30 s to wash the column. Flow-through was discarded. As residual 
ethanol could affect the quality o fDNA and inhibit subsequent enzymatic reactions, 
the column was further centrifuged for 3 min to ensure all residual ethanol had been 
removed. Finally, the column was transferred to a clean eppendorf tube. 50 \i\ of 
warm water was added to the column membrane. The tube was allowed to stand at 
room temperature for 2 min, and centrifuged at 13,000 rpm for 2 min. The eluted 
DNA was stored at -20"C for later use. 
2.2.1.9 Confirmation of miniprep product bv restriction enzvme disestion 
Restriction enzyme digestion of the plasmids was performed in 20 |il at 37 °C for 2 
hours to yield the original inserts. Details of the reaction mixture are listed in Table 
2.9. After digestion, 6X DNA loading dye was added to stop the reaction and the 
size of insert was checked by agarose gel electrophoresis. 
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Table 2.9 — Restriction digestion mixture for confirming miniprep products 
NP mutant 
dH2O 14^il 
Miniprep products 4 |xl 
10X Reaction buffer (New England BioLabs Inc.) 1 ^1 
EcoRl/Bamm (10 U, New England BioLabs Inc.) 0.5 i^l 
HmdlU/Xhol (10 U，New England BioLabs Inc.) 0.5 i^l 
Total 20 i^l 
2.2.1.10 Seauencins of the plasmid DNA 
1 i^g of each of the plasmid DNA was sent to Tech Dragon Limited to perform 
sequencing with MBP sequencing forward primer (5'-CGA GCT CGA ACA ACA 
ACA-3，），standard T7 promoter or standard T7 terminator reverse primer. The 
sequencing results were aligned with the A>^ongKong/156/97(H5Nl) NP gene 
(NCBI accession code: AF036359), human importin-al (NCBI accession code: 
AAH67848), importin-a3 (NCBI accession code: AAC25605) or importin-a5 (NCBI 
accession code: EAW79483) using the program ClustalW to check for undesired 
mutations. 
2.2.2 Expression of the Recombinant NP-WT/ mutants 
and importin al , 3 and 5 in E, coli 
2.2.2.1 Transformation and platins out transformants for protein expression 
After confirming the sequence of the insert was correct, 1 i^l of miniprep product 
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from NP-WT/ mutants and importin-al, 3 and 5 was added individually to eppendorf 
tube containing 100 i^l of freshly thawed E. coli strain 
BL21(DES)pLysS competent cells respectively. It was incubated on ice for 1 min, 
followed by 2 min at 42 °C for heat shock, and 1 min on ice. The content was then 
spread evenly onto each LB agar plates containing 100 ^ig/ml of ampicillin/ 50 p_g/ml 
ofkanamycin and 50 ^ig/ml of chloramphenicol. The plates were incubated at 37 °C 
for 16 hours. 
2.2.2.2 Preparation of starter culture 
Single bacterial colony was picked and inoculated into 20 ml of LB 
medium containing 100 ^g/ml of ampicillin/ 50 ^ig/ml ofkanamycin and 50 ^ig/ml 
of chloramphenicol. The culture was incubated at 37 ®C for 8 hours with constant 
shaking at 250 rpm. 
2.2.2.3 Expression of recombinant protein 
20 ml of starter culture was added into 2 L ofM9ZB medium containing 100 ^ig/ml 
of ampicillin/ 50 ^ig/ml of kanamycin and 50 ^ig/ml of chloramphenicol. It was 
incubated at 25 °C for 16 hours with constant shaking at 250 rpm. 
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2.2.2.4 Cell harvestins 
Cells were harvested by centrifugation at 4 °C, 8,000 rpm for 5 min (Beckman 
JLA-16.250 rotor). The supernatant was discarded, and the cell pellet was either 
resuspended in sonication buffer or stored at -20°C. 
2.2.2.5 Releasins the cell content 
Cell pellet ofNP-WT/ mutants was resuspended in 40 ml of sonication buffer 1 (20 
mM sodium phosphate, 100 mM NaCl, 1 mM EDTA, pH 7.0) containing 1 mM 
PMSF and 10 mM p-ME. Cell pellet of importin-al, 3 or 5 was resuspended in 40 
ml of sonication buffer 2 (20 mM Hepes, 500 mM NaCl, 1 mM MgCb, 5 mM 
imidazole, 20 mM p-ME, pH7.0) containing 1 mM PMSF. The cells were then 
lysed by sonication with sonication probe for 8 cycles of 30-second bursts with 30 s 
in-between time intervals. During the whole sonication process, the samples were 
kept on ice to avoid drastic temperature rise causing protein denaturation. The 
whole lysate was centrifuged at 4°C, 20,000 rpm for 30 min (Beckman JA-25.50 
rotor) to remove cell debris. Supernatant, pellet and whole lysate were aliquoted for 
Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS-PAGE). 
2.2.2.6 Expression check bv SDS-PAGE 
SDS-PAGE was performed using a Mini-PROTEAN II electrophoresis cell (BioRad 
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Labs). Apparatus was set up according to manual instructions. An inner and an 
outer glass plates were assembled into the cell with two 0.75 mm thick spacers. 
3.2 ml of resolving gel solution was transferred into the space between the inner 
and outer glass plates. 200 i^l of isopropanol was added to the top of the gel to 
ensure a horizontal gel surface and to keep the gel solution away from atmospheric 
oxygen. 
After polymerization of the resolving gel, isopropanol was removed, and stacking gel 
solution was added to the top of the resolving gel until reaching the margin of the 
outer glass plate. A 15-well former comb of thickness 0.75 mm was inserted into 
the gel between the glass plates. Gel compositions are listed in Table 2.10. 
Table 2.10 一 Details for resolving (15%) and stacking (5%) gel for SDS-PAGE 
Resolving Gel (15%) Stacking Gel (5%) 
dH2O 1.7 ml dH2O 2.7 ml 
30% acrylamide solution 3.75 ml 30% acrylamide solution 0.67 ml 
1.5MTris (pH 8.8) 1.9 ml 1.5MTris (pH 8.8) 0.5 ml 
10% SDS 75 i^l 10% SDS 40 ^1 
APS 75 i^l APS 40 i^l 
TEMED 3j^ TEMED 4^1 
Total - 7 . 5 ml Total ~ 4 ml 
After the stacking gel polymerized, the comb was removed. The gel cassette was 
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then assembled into an electrophoresis cell. The inner chamber was filled with 
fresh SDS running buffer; and the outer chamber with re-used SDS running buffer. 
Appropriate volume of 6X SDS gel loading buffer was added to the sample to make 
a final concentration of IX. The samples were then incubated at 95 °C for 5 min. 
After that, a maximum o f l 5 \i\ of the protein samples were loaded into the wells. 3 
|xl of post-stained SDS-PAGE standards (low range) (Bio-Rad, USA) was loaded into 
one o f t h e wells. Electrophoresis was performed at constant current o f 3 5 mA per 
gel until the dye front reached the bottom of the gel. After that, the gel was 
removed from the electrophoresis cell and stained with Commassie Brilliant Blue 
staining solution for 1 hour or more with continuous shaking. The gel was then 
destained by incubating in de-stain solution until destaining was completed. After 
destaining，the gel was equilibrated in distilled water. 
2.2.3 Purification of the NP-WT/ variants 
Maltose-binding protein (MBP)-tagged NP-WT and its mutants were expressed in 
E. coli. They were first purified by amylose affinity chromatography. The 
MBP-tag and RNA were then removed by thrombin (Sigma) and RNaseA (USB). 
They were then purified by heparin affinity chromatography. 
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2.2.3.1 Amvlose affinity chr0mat02raphv 
Soluble fraction ofthe cell lysate containing the released protein was first purified by 
a 20 ml affinity column, Amylose sepharose (New England BioLabs Inc.). The 
binding buffer (purification buffer A1) was 20 mM sodium phosphate, 100 mM NaCl, 
1 mM EDTA, pH 7.0 while the elution buffer (purification buffer A2) was 20 mM 
sodium phosphate, 100 mM NaCl, 20 mM maltose, pH 7.0. 
Amylose affinity chromatography was carried out as follows: 
The amylose column was washed with 50 ml of elution buffer at 2 ml/min to wash 
away residual proteins remained in the column.The amylose column was 
equilibrated with 80 ml of binding buffer at 2 ml/min.Soluble fraction of the cell 
lysate was loaded onto the column at 1 ml/min. Flow-through was collected. The 
amylose column was washed with binding buffer at 2 ml/min to wash away any 
non-specific bound materials on the column until absorbance became steady. Flow-
through was collected. Proteins were eluted with elution buffer at 2 ml/min in a 
gradient of 0 to 100 % 20 mM maltose. The total elution volume is 90 ml, with 3 
ml/fraction. Loading, flow-through and eluted fractions were analyzed by 15% 
SDS-PAGE to trace for MBP-tagged NP-WT/ mutants. The eluted proteins were 
stored at 4 °C. 
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2.2.3.2 Removal 0fMBP-ta2 and RNA 
From the SDS-PAGE, the protein-containing fractions were identified. These 
fractions were subject to thrombin (Sigma) and RNaseA (USB) digestion. 100 U of 
thrombin and 100 U of RNaseA were added for protein expressed in 2 L of 
bacterial culture. The digestion was carried out at 4 °C for 16 hours. 
2.2.3.3 Heparin affinity chromatosravhv 
5 ml HiTrap™ Heparin^^ HP column (GE Healthcare) was used in the 
second purification step. The binding buffer (purification buffer B1) was 20 mM 
sodium phosphate, 100 mM NaCl, pH 7.0 while the elution buffer (purification 
buffer B2) was 20 mM sodium phosphate, 1.5 M NaCl, pH 7.0. 
Heparin affinity chromatography was carried out as follows: 
The heparin column was washed with 20 ml of elution buffer at 3 mlAnin to wash 
away residual proteins remained in the column. The heparin column was 
equilibrated with binding buffer at 3 ml/min until conductivity became steady. The 
digested proteins were loaded onto the heparin column at 1 mlAnin. Flow-through 
was collected. The heparin column was washed with binding buffer at 3 ml/min to 
wash away any non-specific bound materials on the column until absorbance became 
steady. Proteins were eluted with elution buffer at 2 ml/min in a gradient o f O t o 100 
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% 1.5 M NaCl. The total elution volume is 100 ml, with 5 ml/fraction. Loading, 
flow-through and eluted fractions were analyzed by 15% SDS-PAGE to trace for NP. 
The eluted proteins were stored at 4 °C. 
From the SDS-PAGE, fractions containing NP-WT/ mutants were 
pooled and concentrated to about 5 ml using Amicon Ultra-15 Centrifuge Filter Units 
(Millipore) with 10,000 MWCO at 4,000 rpm at 4 °C. The concentrated proteins 
were frozen in liquid nitrogen and stored at -80 °C until use. 
2.2.4 Purification of the importin al , 3 and 5 
His-tagged importin a l , 3 and 5 were expressed in E. coli. They were first 
purified by Metal chelating IMAC affinity chromatography and then by gel filtration. 
2.2.4.1 Metal chelatin2 IMAC affmitv chr0mat02raDhv 
Soluble fraction of the cell lysate containing the released protein was first purified by 
a 5 ml Metal chelating IMAC affinity column (GE Healthcare). The binding buffer 
(purification buffer C1) was 20 mM Hepes, 500 mM NaCl, 1 mM MgCb, 5 mM 
imidazole, 20 mM P-ME, pH 7.0. while the washing buffer (purification buffer C2) 
was 20 mM Hepes, 1 M NaCl, 1 mM MgCb，25 mM imidazole, 20 mM p-ME, pH 
7.0. The elution buffer (purification buffer C3) was 20 mM Hepes, 500 mM NaCl, 1 
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mM MgCl2, 1 M imidazole, 20 mM P-ME, pH 7.0. 
Metal chelating IMAC affinity chromatography was carried out as follows: 
The metal chelating IMAC column was chelated with 50mM EDTA at lml/min. 
The column was then washed with deionized distilled-water at lmlAnin. It is 
then coupled with 50mM NiSO4 at lml/min and subsequently washed with 
deionized distilled-water again. The column was washed with 30 ml ofelution buffer 
(Purification buffer C3)at 3 ml/min to remove residual proteins in the column. It was 
equilibrated with 50 ml of binding buffer (Purification buffer C1) at 3 mL'min. 
Soluble fraction of the cell lysate was loaded onto the column at 1 ml/min. 
Flow-through was collected. The column was washed with washing buffer 
(Purification buffer C2) for at least 1 hour at 3 ml/min to remove non-specific 
bound materials on the column until absorbance became steady. Flow-through 
was collected. The column was equilibrated by the binding buffer (Purification buffer 
C1) at 3 ml/min. Proteins were eluted with elution buffer (Purification buffer C3) at 3 
ml/min in gradient ofO-100% 1 M imidazole. The total elution volume is 80 ml, with 
4 ml/fraction. Loading, flow-through and eluted fractions were analyzed by 15% 
SDS-PAGE to trace for His-tagged importin-al, 3 and 5. The eluted proteins were 
stored at 4 ®C. 
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From the SDS-PAGE，fractions containing His-tagged importin-al, 3 and 5 were 
pooled and concentrated to about 5 ml using Amicon Ultra-15 Centrifuge Filter Units 
(Millipore) with 10,000 MWCO at 4,000 rpm at 4 � C . Buffer exchange with the gel 
filtration buffer was carried out for at least 2 times. The concentrated proteins were 
stored at 4 ®C until use. 
2.2.4.2 Gel filtration chr0mat02raphv 
SuperdexTM 75 gel filtration column was used to remove small molecules from the 
protein solution. The buffer used was 20 mM Tris-HCl, 200 mM NaCl, 2 mM DTT, 
pH 8.0., which was filtered through a 0.22 i^m filter cup and autoclaved. 
Gel filtration chromatography was carried out as follows: 
The gel filtration column was equilibrated with 500 ml buffer at 3 mL'min to wash 
away the 20 % ethanol, which is for column storage. The sample loop was 
washed with 30 ml buffer and the concentrated protein solution was injected into the 
sample loop. Flow rate was resumed (3 ml/min) and eluted fractions 
were collected in 2 ml/tube. Loading and eluted fractions were analyzed by 15% 
SDS-PAGE to check for the purity of importin-al, 3 and 5. The eluted proteins were 
stored at 4 X . 
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From the SDS-PAGE, fractions containing His-tagged importin-al, 3 and 5 were 
pooled and concentrated to about 5 ml using Amicon Ultra-15 Centrifuge Filter Units 
(Millipore) with 10,000 MWCO at 4,000 rpm at 4 � C . Buffer exchange with the 
exchange buffer (20 mM Tris-HCl, 100 mM NaCl, 2 mM DTT, pH 8.0) was carried 
out for at least 2 times. The concentrated proteins were frozen in liquid nitrogen 
and stored at -80 °C until use. 
2.2.5 In vitro interaction study between NP and importin a 
2.2.5.1 Pull down assay 
5mg N-terminal truncated importin-al, 3 and 5 in coupling buffer (0.2 M NaHCO3, 
0.5 M NaCl, pH 8.3) were injected into three individual NHS columns following the 
manufacturer's instruction. The column was stood for 1 hour. Excess active 
groups and non-specifically bound ligands were removed by alternative application 
ofwash buffer A (0.5 M ethanolamine，0.5 M NaCl, pH 8.3) and wash buffer B (0.1 
M acetate, 0.5 M NaCl, pH 4). The column was stored in 20 mM sodium phosphate, 
1 M NaCl, pH 7.0 at 4 °C until use. 
1 ml of purified NP-WT was applied to importin-al, 3 and 5-coupled NHS columns 
and incubated for one hour. Non-specific protein was washed with 20 ml buffer A 
(20 mM sodium phosphate, 150 mM NaCl, pH 7)，followed by elution of bound 
56 
protein with buffer B (20 mM sodium phosphate, 1 M NaCl, pH 7). The eluted 
fractions were analyzed by 15% SDS-PAGE. The same procedures were also applied 
to uncoupled NHS column as a control. 
2.2.5.2 Static Lisht scatterins analysis 
Static light scattering analysis was performed to determine the binding ratio between 
N-terminal truncated importin-a5 and RNaseA-treated NP-WT. A tri-angle (45°, 
90。，135°) light scattering detector miniDAWN (Wyatt Technology Corporation, 
Santa Barbara, CA) connected with an interferometric refractometer OPTILAB DSP 
(Wyatt Technology Corporation) were used. This system was connected to a 
SuperdexTM 10/300 GL Column (GE Healthcare), controlled by an 
AKTAexplorer chromatography system. Before sample injection, the miniDAWN 
detector system was equilibrated with Light Scattering running buffer 1 (20 mM 
Tris-HCl, 200 mM NaCl, 2 mM DTT, pH 8.0, 0.1 i^m filtered) for no less than two 
hours to ensure stable baseline signals. The flow rate was set to 0.7 ml/min and the 
sample volume was 100 ,^1. The laser scattering (690 nm) and the refractive index 
(690 nm) of the respective protein solutions were recorded during the measurement 
processes. Wyatt software ASTRA was used to evaluate all data obtained. 
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2.2.5.3 BL4core 3000 surface Plasmon resonance 
BIAcore 3000 surface plasmon resonance biosensor (Pharmacia Biosensor AB) was 
performed to measure the kinetic parameters for the interaction between importin-a5 
and NP-WT/ NLS mutants. Experimental design, operating procedures and data 
analysis were derived from the instructions depicted in BIAcore 3000 Getting Started, 
BIAtechnology Handbook, Sensore Surface Handbook and BLicore 3000 
Instructment Handbook. BIAcore 3000 was controlled by the BIA3000 Control 
Sorftware and data analysis was done using BIAevaluation Software. 
2.2.5.3.1 Immobilization of importin-aS onto CM5 sensor chips 
Truncated importin-a5 was diluted to 50 ^ig/ml by BIAcore immobilization running 
buffer (20 mM Hepes, 100 mM NaCl, 0.005 % Tween-20, pH 7) and was 
immobilized onto CM5 sensor chips at their primary amide group (N-terminal 
amides and amide groups of the side-chain of Lys) using the Amine Coupling Kit 
(Pharmacia). A freshly opened CM5 sensor chip was docked onto the sensor chip 
rack in BIAcore 3000 and was activated by 1:1 EDC (0.4 i^M 
l-ethyl-3-(3-dimethylaminopropyl)-carbodiimide in water) and NHS (0.1 p,M 
N-hydroxysuccinimide in water) at 5 p.l/min for 10 minutes. 50 ^ig/ml importin-a5 
was then passed through to the chip at 5 p,i/min for 10 minutes. 1 M ethanolamine 
(pH8.5) was then injected at 5 |xL^min for 5 minutes to deactivate the excess reactive 
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group on the sensor surface. A total of 428 Response Unit (RU) of importin-a5 was 
immobilized. The chip was then equilibrated with BIAcore running buffer (20 mM 
Tris-HCl, 150 mM NaCl, 2 mM DTT，5 % glycerol, 0.005 % Tween-20 pH 8.0) at 5 
fj,l/min for 5 minutes before kinetic measurement. 
2.2,5.3.2 Kinetic measurement 
0-100 nM NP-WT/ NLS mutants in BIAcore running buffer was injected at 30 
^|y'min, 25 °C, onto the importin-a5-immobilized sensor chip surface. The binding 
surface was regenerated by 2M NaCl. Control experiment was carried out similarly 
on uncoupled sensor chip surface. For all BIAcore experiments, a steady 
and consistent baseline was attended by washing the sensor chip using the 2 M NaCl 
before starting a new association /dissociation cycle. The binding affinity 
was calculated by BIAevaluation Software using 1:1 binding with drifting baseline. 
2.2.6 In vivo interaction study between NP and importin a 
2.2.6.1 Co-purification of NP and importin aS 
NP-NLS mutants and full-length importin a5 were co-transformed to E. coli strain 
BL21(DES)pLysS competent cells and the transformants were selected by both 
ampicillin and kanamycin. Colony was inoculated in 5ml LB with supply of 
ampicillin, kanamycin and chloramphenicol and allowed to grow with shaking with 
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250 rpm under 30 °C for 16 h. Cells were harvested and sonicated. Similar 
purification method as described in 2.2.3 was applied and SDS-PAGE was 
performed to check for the appearance of importin a5 and MBP-NP WT/ variants. 
2.2.6.2 Co-immunoDreciDitation of NP and Importin a5 
2.2.6.2.1 Cell culture of293T/l 7 human kidnev epithelial cells 
293T/17 cells were cultured in minimum-essential medium (MEM) 
supplemented with 10 % fetal bovine serum. The cells were grown in a 95 % O2/ 5 
0/0 CO2 water saturated incubator at 37 °C. Medium was renewed every two to three 
days. Cells were sub-cultured whenever reached confluency at a ratio o f l : 3 to 1:8. 
0.25 % (w/v) Trypsin-0.53 mM EDTA solution was used to detach the cells during 
sub-culture. Cells were preserved in 95 % complete culture medium with 5 % 
DMSO in liquid nitrogen. 
2.2.6.2.2 Transfection 
1.0 p,g of each of the myc-tagged NP WT/ NLS mutant plasmids 
and Flag-tagged full-length importin a5 were diluted to a total volume o f250 ,^1 in 
OptiMEM (Invitrogen) and subsequently added to a mix of 6 p.1 of Lipofectamine 
2000 (Invitrogen) in 250 …OptiMEM. The transfection mixture was incubated for 
30 minutes. During the incubation time, a 1.5 ml (about 10^ cells) 293T cell in a 
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suspension in minimal essential medium (MEM) containing 10% fetal calf serum 
was prepared in 35-mm dishes. The transfection mixture was finally 
added drop-by-drop to the 293T cells prepared and incubated in a 95 % O2/ 5 % CO2 
water saturated incubator at 37 °C. 
2.2.6.2.3 Co-immunoprecipitation 
Co-immunoprecipitation was used for three different experiments. 1 i^g each of 
untagged and myc-tagged NP plasmids in the NP homo-oligomerization experiment, 
1 i^g each of myc-tagged NP and flag-tagged importin-a5 plasmids in NP-importin 
interaction experiment and 1 i^g each of myc-tagged PA, untagged PB1 and PB2 with 
various untagged NP mutants in the NP-polymerase interaction experiment were 
transfected into 10^ human kidney 293T cells in suspension in respective 
experiments. Co-immunoprecipitation was performed 48-hours post-transfection. 
Cells were resuspended in co-IP buffer (50 mM Tris-HCl (pH 7.6)，150 mM NaCl, 1 
mM EDTA) with 1 % Triton X-100 added in the previous day of experiment. 
Sonication was performed at constant burst for 5 s to lyse the cells and the lysate 
was centrifuged at 16000 g for 10 minutes at 4°C. The supernatant was incubated at 
4°C overnight with or without anti-myc Ab. The mixture was then incubated with 
15 i^l protein-A beads for 1.5 hours at 4°C with shaking. The beads 
were centriftiged and washed with co-IP buffer three times before being boiled in 
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SDS-loading dye and analyzed by 10% SDS-PAGE and subsequent by western 
blotting. 
2.2.6.2.4 Western Blot analysis 
PVDF (polyvinylidene difluoride) membrane was first immersed in methanol for 30 
sec and transferred to transfer buffer (25mM Tris, 192mM glycine and 10% 
methanol) for 3-5 min. The resolved proteins were transferred from gel to PVDF 
(polyvinylidene difluoride) membrane by semi-dry transfer at 15 mA for 45 min in 
transfer buffer. The membranes were then removed from the transfer apparatus 
and immediately placed into blocking buffer (5% milk powder dissolved in TBST) 
for 30 min at 37�C. The blot was then removed from the blocking buffer 
and incubated with the anti-myc/ anti-flag monoclonal primary antibody (1: 2000) 
in 5 ml of blocking buffer overnight at 4°C. After primary antibody blotting, the 
primary antibody solution was decanted and 5 ml TBST was added and washed for 
30 min with agitation, changing the wash buffer every 5 min. The secondary 
Anti-mouse IgG antibody (1: 2000) in 5 ml blocking buffer was added to the blot. 
The blot was then incubated with agitation for 1 hr at room temperature. Afterwards, 
the secondary antibody solution was decanted and 5 ml wash buffer was 
added and rinsed for 30 min with agitation, changing the wash buffer every 5 min. 
The blot was placed in a clean tray containing chemiluminescent working solution 
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(Amersham ECL Western blotting detection reagents and analysis system, GE 
Healthcare). The final volume required was 0.125 ml/cm^ membrane. The tray was 
rotated on orbital shaker to cover the surface of the membrane for 1-2 min. The 
membrane was then placed on a clean wrap and excessive detection reagent and air 
bubbles were drained off and smoothed out gently. The wrapped blot was then 
placed in an X-ray film cassette and exposed to a sheet ofX-ray film (Super HR-T 30’ 
Fujifilm). After exposure o f l5 -60 sec, the film was developed immediately. 
2.2.6,3 Analysis ofmRNA as a representative ofRNP activity bv ORT-PCR 
1.0 i^g ofeach o f the pcDNA-PBl, pcDNA-PB2, pcDNA-PA, pcDNA-NP WTVNLS 
mutants and pPOLI-NA-RT were transfected to human kidney 293T cells to 
reconstitute RNP complexes. Total RNA was extracted post-48 h of 
transfection. Oligo(dT)-primed cDNA were synthesized from total RNA using 
SuperScript kit (Invitrogen) according to the manufacturer's protocols. cDNA 
was amplified using SYBR® Green PCR Master Mix (Applied Biosystems) in a 
total reaction of 25^il. NA-gene specific primer with 
sequence 5'-TCCAGTATGGTTTTGATTTCCG-3' was used. Human beta-actin 
was used as endogenous control. The thermal cycling conditions were 95°C 10 
min, followed by 40 cycles of 95°C 10 s, 60°C 60s. The amplification products 
were detected with a 7500 sequence detection system (Applied Biosystems). 
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Samples were normalized to the endogenous control and the data was 
analyzed with the delta delta Ct (ddCT) method. 
2.2.7 In vivo analysis to study NP-NP homo-oligomerizarion 
2.2.7.1 In vivo RNA analysis to studv NP-NP homo-olisomerizarion 
2.2.7.1.1 Checkins protein expression of NP variants 
Human kidney 293T cells were used to check for the NP variant expression. 
Different amount ranging from 1.0-4.0 i^g of NP plasmids were transfected to 
293T cells. Transfected cells were harvested post-48 hour and the lysate were 
analyzed by SDS-PAGE and subsequent western blot to ensure the amount of NP 
variants expression were similar. 
2.2.7.1.2 RNP reconstitution 
Human kidney 293T cells were used to reconstitute RNP complexes. 1.0 ^g of each 
o f t h e pcDNA-PBl, pcDNA-PB2, pcDNA-PA, pPOLI-NA-RT，and various amount 
of pcDNA-NP plasmids were transfected to Human kidney 293T cells to reconstitute 
RNP complexes by method described in 2.2.6.2.2. 
2.2.7.1.3 Total RNA extraction 
Cells were harvested 48 hours post-transfection. Medium was discarded and 1ml of 
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TRIzoI reagent (Invitrogen) was added to incubate for 5 minutes. All cells were 
resuspended and transferred to an Eppendorf tube. 200 _^1 chloroform was 
added and mixed by inverting the tube. After 5 minutes incubation, the mixture 
was centrifuged at 13000 rpm for 20 minutes at 4°C. 500 i^l of the top clear layer was 
subjected to mix with 500 i^l isopropanol for 5 minutes. A pellet was clearly seen 
after centrifugation at 13000 rpm for 20 minutes at 4°C. Supernatant was 
removed and 1 ml of70% ethanol was added. The tube was centriftiged at 13000 rpm 
for 10 minutes at room temperature. The pellet was air-dried after the ethanol was 
removed. 30 fxl of RNAse-free water was added to dissolve the pellet and the RNA 
was stored at -20°C. 
2.2.7.1.4 Speciroph otometric analysis of total RNA 
The quantity and purity of RNA were determined by optical density measurement. 
Quantization o fRNA was done by measuring absorbance o fRNA samples at 260 nm. 
OD unit at 260 nm corresponds to 40 p-g/ml of RNA. RNA concentration was 
estimated by applying the Beer's Law “ A=sbc", where: A: Absorbance; e: Molar 
absorptivity (Lmor'cm' '); b: Path length of sample (cm); c: Concentration 
of compound in solution (molL"') 
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2.2.7.1.5 Primers labelin2 
Two NA gene-specific primers 5'-GGACTAGTGGGAGCATCAT-3' (to detect 
vRNA), 5‘-TCCAGTATGGTTTTGATTTCCG-3‘ (to detect mRNA and cRNA) 
and one 5S ribosomal RNA primer 5‘-TCCCAGGCGGTCTCCCATCC-3‘ (to 
detect 5S rRNA as an internal control) were labeled. They were first diluted to 
lOpmoi4d. Phosphorylation of the primers was done by incubating the reaction 
mixture as show in table at 37°C for 1 hour. Detailed reaction conditions of primer 
phosphorylation are listed in table 2.11. 
Table 2.11 [y-32P] phosphorylation ofprimers 
10X PNK buffer (Roche) 1 i^l 
[y-32P] ATP 1 i^l 
primer 1 M-1 
PNK enzyme (40 U/^1, New England BioLabs Inc.) 1 i^l 
ddH2O 6^il 
Total lO^il 
The reaction was stopped by adding 50^il PN buffer. The total 60^il mixture was 
loaded to oligo-binding column sitting in the collection tube from Nucleotide 
Removal Kit (Qiagen). The columns was centrifuged at 13000 rpm for 1 minute 
and washed with 400pJ PE buffer for times. An extra centrifuge step was 
performed to remove trace alcohol. The radioactive primers labeled at its 5’ end with 
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32p were eluted with 30^il ddH2O and stored at -20°C. 
2.2.7.1.6 Primer extension assay 
An excess ofDNA primers mix (about 10^ cpm), was mixed with 5 ^g oftotal RNA 
in 5 i^l of water, and denatured at 95°C for 3 minutes. The mixture was cooled on 
ice and subsequently incubated at 45°C for 1 hour with the addition of 50 U 
SuperScript II RNase H" reverse transcriptase (Invitrogen) in First Strand Buffer 
(Invitrogen). Detailed conditions of primer extension assay are listed in table 2.12. 
Table 2.12 Primer extension reaction mixture 
NA gene-specific primer 1 (hot) 0.25 i^l 
NA gene-specific primer 2 (hot) 0.25 i^l 
5S ribosomal RNA primer (hot) 0.25 i^l 
5S ribosomal RNA primer (cold) 0.25 i^l 
5X First Strand Reaction buffer 2 ^1 
lOOmMDTT 1 ^ 1 
lOmM dNTP (2.5 mM each ofdATP, dCTP, dGTP and dTTP) 0.5 i^l 
SuperScript II RNase H" Reverse Transcriptase 0.25 ^1 
ddH2O 4.25 i^l 
Total 9^il 
Reactions were stopped by the addition o f 8 fxl90 % formamide and heating at 95 °C 
for 3 minutes. lOfxl transcription products were loaded and resolved on 6 % 
polyacrylamide gels containing 7M urea in TBE buffer under 1000V. The gel was 
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detected by autoradiography with X-ray film (BioMaxMS, Kodak). Phosphorimage 
analysis by ImageQuant TL (GE Healthcare, Waukesha, WI, USA) was used for 
quantification. An unpaired Student's Mest was used for analysis of significance. 
2,2.7.2 Co-immunoDrecivitation of NP-0li20 variants 
1.0 |ig of each of the myc-tagged NP and untagged NP plasmids were 
transfected 293T cells and co-IP was performed by method as described in 2.2.6.2. 
100 U of RNaseA was added to digest cellular RNA. Western Blot was 
performed by the primary anti-NP polyclonal antibody (1:8500) and the secondary 
anti-rabbit IgG(l:10000). 
2.2.8 In vitro static light scattering analysis to determine NP 
oligomeric state 
Static light scattering analysis was performed to determine the oligomeric state of 
different NP-oligo mutants. Similar method was described in 2.2.5.2, but with light 
Scattering running buffer 2 (20 mM sodium phosphate, 150 mM NaCl, pH 8.0，0.1 
^m filtered, for NP-oligo mutants) used instead. For the R267A mutant, a 1850-nt 
long RNA was transcribed from pTRI-Xef in vitro (Ambion, Austin, TX, USA) 
and added to the protein solution. 
68 
2.2.9 Control experiments to verify NP-polymerases and NP-RNA 
interaction 
2.2.9.1 Co-immunoDrecivitation of NP and polymerases 
1.0 i^g ofeach o f the myc-tagged PA，pcDNA-PBl, pcDNA-PB2 and untagged NP 
WT/mutant plasmids were transfected 293T cells and co-IP was performed as 
described in 2.2.6.2. Western Blot was performed by the primary anti-NP polyclonal 
antibody (1:8500) and the secondary anti-rabbit IgG (1:10000) or the primary 
anti-myc monoclonal antibody (1:2000) and the secondary anti-mouse IgG (1:2500). 
2.2.9.2 Gel shift assav to determine NP-RNA interaction 
24-nt 2'0-methylated RNA oligo of sequence 5, UUU GUU ACA CAC ACA CAC 
GCU GUG 3’ was purchased (RiboBioscience, Guangzhou, China). Fixed amount 
of RNA (10 ^M) was incubated with increasing amount of purified NP wild-type or 
protein variants (0, 5，10，20 p.M) for 30 minutes at room temperature. The mixture 
was subject to agrarose gel electrophoresis and visualized by ethidium bromide 
staining. 
2.2.9.3 BL4core3000 surface Plasmon resonance to determine NP-RNA 
interaction 
BIAcore 3000 surface plasmon resonance was performed to measure the kinetic 
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parameters for the interaction between NP-oligo mutants and RNA. 
2.2.9.3.1 Immobilization of biotinvlated RNA onto SA sensor chips 
Sensor Chip SA (GE Healthcare) was conditioned with three consecutive injections 
of lM NaCl/ 50mM NaOH (100 i^l at 50 ^il/min) to remove any 
unconjugated streptavidin. Biotinylated 2'-0-methylated RNA oligonucleotide with 
the sequence 5' UUU GUU ACA CAC ACA CAC GCU GUG 3' was prepared as a 
1 i^M solution in running buffer (10 mM Tris-HCl, 150mM NaCl, pH 8), heated to 
80 for 10 min and cooled slowly to room temperature. The RNA solution was then 
diluted 500-fold in Tris/NaCl running buffer supplemented with 0.005% surfactant 
P20, 62.5 \ig/m\ BSA, 125 ^ig/ml tRNA, lmM DTT and 5% glycerol. Immobilization 
was then carried out using a series of 10-20 i^l injections at a flow rate of 10 i^Umin, 
repeated until the 30-35 response units (RU) immobilization level was achieved. 
2.2.9.3.2 Kinetic measurement 
0-125 nM/ 0-1000 nM/ 0-4000 nM NP-oligo mutants in BIAcore running buffer 
were injected at 30 pJ/min，25 °C, onto the RNA-immobilized sensor chip surface. 
The binding surface was regenerated by 2M NaCl. Control experiment 
was carried out similarly on uncoupled sensor chip surface. For all BIAcore 
experiments, a steady and consistent baseline was attended by washing the 
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sensor chip using the 2 M NaCl before starting a new association /dissociation cycle. 
The binding affinity was calculated by BIAevaluation Software using 1:1 binding 
with drifting baseline. 
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Chapter 3 
Functional analysis of influenza H5N1 nucleoprotein tail loop for oligomerization 
and ribonucleoprotein activities 
3,1 Introduction 
The genome of influenza A virus contains eight single-stranded negative-sense RNA 
segments (vRNA). These RNA segments interact with multiple copies of 
nucleoprotein (NP) and three polymerase subunits (PA, PB1 and PB2) to form 
ribonucleoprotein complexes (RNP) {Murt1 et al., 1988). In the virus particle, the 
RNP complexes are organized into a distinct pattern, as visualized by transmission 
electron microscopy (EM) (Noda et al., 2006). 
NP not only encapsidates the viral RNA, it also forms homo-oligomers to maintain 
the RNP structure (Prokudina-Kantorovich and Semenova, 1996). 
Homo-oligomerization of NP forms a major part of the RNP complex (Pons et al., 
1969), as observed in purified intact viral RNP under EM {Ruigrok and Baudin, 1995) 
and in mini-RNP (Area et al., 2004; Martin-Benito et al., 2001). Removal of RNA 
from RNP does not affect the rod like structure of RNP. This suggests a direct 
protein-protein interaction between NP monomers to maintain the RNP structure 
(Ruigok and Baudin, 1995). It is the RNP structure rather than the naked vRNA that 
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acts as the template for transcription and replication in the infected cell (Bishop et 
al., 1971). NP homo-oligomerization was found to be promoted by two positive 
elements (amino acids 189-358, 371-465) but inhibited by a negative element 
(amino acids 465-498) (Elton et al., 1999). However, the correlation between NP 
homo-oligomerization and transcriptional function is ambiguous, since amino acid 
substitutions in both the positive (R199A, R416A) and the negative elements {F479A) 
showed decreased transcriptional competence (Elton et al., 1999). Nonetheless, NP 
oligomer is important for the formation of transcriptionally active RNP. 
The structure of H5N1 nucleoprotein reveals that it contains head and body 
domains arranged in a banana shape, with a flexible tail loop (residues 402-428) 
reaching out between of the two domains. It was found that insertion of tail loop 
from one NP protomer to the body domain of the neighboring protomer mediates 
trimerization (Ng et al., 2008). Extensive interactions within the tail loop as well as 
between the tail loop and the body domain were formed to maintain the tail loop 
conformation and facilitate its insertion. Same mechanism is hypothesized for the 
process of oligomerization. In the formation of NP oligomers, the tail loop of NP has 
to be bent towards the body domain, through the two flexible linker regions linking 
the tail loop (Coloma et al., 2009; Ng et al., 2008). Single mutation of residues E339 
and R416, which are involved in the interactions, were found to be impaired in 
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self-association completely (Elton et al., 1999; Ye. et ol., 2006). Due to the extensive 
interactions found within the tail loop and between the tail loop and the main body； 
some other residues are also likely to be important for oligomerization. 
Identification of the essential molecular contacts between neighboring NP proteins 
will shed light on the tail loop insertion process and provide valuable information for 
NP inhibitor design. 
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3,2 Results 
3.2,1 Tail loop insertion is maintained by intra- and inter-molecular 
interactions 
As observed from the trimeric structure, NP homo-oligomerizes by inserting the tail 
loop (amino acids 402-428) into the groove of the body domain of its neighboring 
NP(Figure3.1). 
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Figure 3.1 Crystal structure NP. NP consists of head and body domains and a long 
tail loop, which inserts into neighboring NP to form homo-oligomers. 
It is hypothesized that NP uses the same mechanism in forming oligomeric NP in the 
RNP structure (Ng et al., 2008). Two forces appear to govern the insertion: 
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maintenance ofthe tail loop structure and interaction between the tail loop and the 
groove, and these are summarized by schematic diagrams in Figures 3.2A and 3.2B 
respectively. The tail loop structure is apparently maintained by three clusters of 
residues, namely T1, T2 and T3, at the tip, stem and base. T1 involves a salt bridge 
centered at R416, whose side chain interacts with the main chain of F412 and 
V414. T2 is situated at the stem and forms a zig-zag pattern of hydrophobic 
interactions between V408, P410, L418 and P419. T3 is another hydrophobic 
cluster centered at 1406 which interacts with E421 and 1425. T3 seems to play a 
role in stabilizing the base of the tail loop. The tail loop insertion event is observed 
to involve five clusters of residues, 11 to 15. 11 and 12 involve salt bridges at the tip 
region, featuring interactions among R416, E339, T411, S335 and T390. 13 is 
located at the stem, and centered at R267, which interacts with S407, V408, L418 
and P419. 14 is a hydrophobic cluster of F420, 1265 and P453 at the stem. 15, 
situated at the base, involves a salt bridge between R422 and E449. 
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Figure 3.2 Tail loop interaction of NP. (A) lntra-chain interaction of the tail loop. 
Three regions of molecular contacts are identified from the NP crystal structure. T1 
(dotted lines) involves hydrophilic interaction while T2 and T3 (double solid lines) 
involve hydrophobic interactions. (B) Inter-chain interaction of the tail loop. Most 
of the interactions are hydrophilic in nature (II, 12, 13 and 15) except 14 which is 
hydrophobic. Thickness of the dotted lines indicates the strength of hydrogen 
bond between the two residues. Amino acid residues of the tail loop are indicated 
by circles, while amino acid residues of the insertion groove are indicated by 
squares. 
3.2.2 NP mutants display defective transcription-replication activity 
Since NP is a major component of the RNP complex (Portela and Digard, 2002), it is 
conceivable that mutations in NP may alter the transcription-replication 
activity. Based on the structural information, we first constructed 13 single-point 
and 1 double-point mutants targeting the residues in the eight mentioned clusters 
(Figure 3.2A and 3.2B), in the hope of identifying the crucial residues for the tail 
loop insertion event. Charged residues were mutated to alanine to remove the 
hydrogen bond interaction, while other residues were mutated to serine to remove 
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the hydrophobic interaction. The mutated NP plasmids were then co-transfected 
with plasmids expressing polymerase proteins and a reporter plasmid. The plasmid 
amount was adjusted for individual NP mutants to obtain similar expression levels of 
the protein (Figure 3.3). A plasmid expressing wild-type NP was used as the 
positive control while an empty plasmid was the negative control. 
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Figure 3.3 Western blotting of cell lysates expressing NP mutants. The amount of 
NP-expressing plasmids was adjusted to give similar expression level. Beta-actin 
was used as internal control. 
At 48 hours post-transfection RNA was extracted and the v-, c- and m-RNA levels of 
the reporter gene were quantified by primer-extension assay, followed by 
polyacrylamide gel electrophoresis and autoradiography (Figure 3.4). 
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Figure 3.4 In vivo RNP reconstitution followed by primer extension assay of NP 
mutants. Different pcDNA-NP plasmids were mixed with pcDNA-PBl, pcDNA-PB2, 
pcDNA-PA and pPOLI-NA-RT and transfected into 293T cells. pcDNA3 instead of 
pcDNA-NP was used in the negative control. RNA was isolated from cells after 48 
-hour incubation and analyzed by primer extension assay as described in the 
Material and Methods. Positions of vRNA, mRNA, cRNA and 5S rRNA are indicated 
on the right. A representative result of three independent experiments is shown. 
The various RNA levels were normalized to the internal 5S rRNA control and 
compared with those of the wild-type NP. Among those mutants that were 
constructed to assess the importance of inter-subunit tail loop insertion event for 
transcription-replication activity, E339A and R416A showed nearly undetectable 
activity, R267A, R422A and E449A showed a more than 50% decrease, while T390S, 
S407A, T411S and F420S did not show a significant change (Figure 3.5). On the 
other hand, among mutants that could possibly destroy the tail loop conformation, 
[L418S,P419S] and R416A showed undetectable activity, I406S displayed a more 
than 50% decrease in the RNP activity, while V408S, P410S and I425S did 
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not. When considering the hydrophobic cluster of T2, we wonder if a double 
mutant ofV408S and P410S would give similar result as [L418S,P419S], and whether 
L418S and P419S single-point mutants would resemble V408S or P410S. To address 
this question, we constructed three more mutants: [V408S,P410S], L418S, P419S 
and performed further experiments as described above. We found that 
[V408S,P410S] resulted in nearly non-detectable RNP activity while L418S and P419S 
had no significant change 
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Figure 3.5 Quantitation of mRNA, cRNA, and vRNA. RNA levels for each NP mutant 
were compared to wild-type NP which was set to 100%. 5S rRNA was used as an 
internal control to standardize the RNA level. The results represent the mean 
percentage 土 standard deviation from three independent experiments (*p=0.02; 
**p=0.0005). 
3.2.3 Expression andpurification ofdefective NP variants 
RNP reconstitution assay revealed NP mutants that were defective in 
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oligomerization. They were expressed and purified for further experiments. 
3.2.3.1 Expression ofMBP-taaaed NP and its variants 
Recombinant MBP-tagged NP and its variants were expressed in E. coli strain 
BL21(DE3)pLysS in M9ZB medium at 30 °C for 16 hours. The molecular weight of 
them was estimated to be around 100 kDa by the program PortParam. The cells 
were harvested and proteins were released by sonication. The supernatant, pellet 
and whole lysate of wild-type MBP-tagged NP were analyzed by SDS-PAGE (Figure 
3.6). Most MBP-tagged NP was found in the supernatant portion. The expression 
levels of the NP variants were found to be similar (data not shown). 
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Figure 3.6 Expression of MBP-tagged NP. The target protein was expressed in 
M9ZB medium at 30 °C for 16 hours. It is found that a large proportion of MBP-NP 
was present in the supernatant. 
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3.2.3.2 Purification ofMBP-taaaed NP and its variants 
3.2.3.2.1 Amylose affinity chromatography 
MBP-NP-containing soluble fraction of the cell lysate was applied to an affinity 
column, amylose sepharose. MBP-NP was eluted by a 0-100 % of20 mM maltose 
gradient. The elution profile is shown in Figure 3.7. Eluted fractions were 
collected and analyzed by SDS-PAGE (Figure 3.8). MBP-NP was mainly eluted 
from fractions 8 to 11 (3 ml/fraction). Other NP variants were purified according to 
the above protocol (data not shown). 
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Figure 3.7 Elution profile of amylose column chromatography. MBP-NP was 
eluted by a 0-100 % of 20 mM maltose gradient. The protein was eluted from 
fractions 7-15, with 3 ml/fraction. 
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Figure 3.8 SDS-PAGE of fractions from amylose column chromatography. 
MBP-NP was mainly eluted from fractions 8 to 11. 
3.2.3.2.2 Removal ofMBP-tag and RNA 
The fractions containing the eluted MBP-tagged NP were pooled and subject to 
thrombin and RNaseA digestion at 4 ®C for 16 hours. Same treatment was also 
carried out on other NP variants. 
3.2.3.2.3 Heparin affinity chromatography 
The thrombin- and RNaseA-digested proteins were loaded onto heparin column. 
MBP-NP was digested into MBP and NP. MBP did not bind onto the column while 
NP did. NP was eluted by a 0-100 % of 1 M sodium chloride gradient. The 
elution profile is shown in Figure 3.9. Loading, flow through and eluted fractions 
were collected and analyzed by SDS-PAGE (Figure 3.10). NP was mainly eluted 
from fractions 13 to 16 (5 ml/fraction). The NP-containing fractions were 
concentrated to 3mg/ml and stored in heparin buffer A (20mM sodium phosphate; 
150mM NaCl; pH6.5). 
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Figure 3.9 Elution profile of heparin column chromatography. Proteins were 
eluted by a 0-100 % of 1 M sodium chloride gradient. NP was eluted from fractions 
13-16, with 5 ml/fraction. 
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Figure 3.10 SDS-PAGE of heparin column chromatography. Loading, flow-through 
and fractions were analyzed. Elution fractions from amylose column 
chromatography were pooled, and digested with thrombin and RNaseA. In lane 
'Load', MBP-NP (102 kDa) was digested into NP (56 kDa) and MBP (46 kDa). MBP 
did not bind to heparin column while most of the NP was bound onto the column, 
as noted from the faint band of NP in the flow through. Proteins were mainly 
eluted from fractions 13 to 16. 
After purification by column chromatography, the purity ofNP-WT and its variants 
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Figure 3.11 SDS-PAGE of NP-WT and its variants. They were found to attain high 
homogeneity. 
3.2.4 Defective NP variants interact with RNA and the polymerase 
complex 
The above work showed that eight NP single- or double- point mutants at the tail 
loop and the groove of insertion exerted a negative effect on the 
transcription-replication activity of RNP. We hypothesized that these mutations 
may disrupt the tail loop insertion event, and thus NP 
homo-oligomerization. However, for a functional RNP, NP has to interact with both 
RNA and the trimeric polymerase complex (Baudin et al., 1994; Biswas et al.,1998; 
Medcalf et al., 1999). Therefore, we first tested whether the eight defective NP 
variants still possessed these essential contacts. 
Increasing amount of eight purified NP variants was incubated with a 24-nucleot1de 
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2'0-methylated RNA oligo. 2'0-methylated RNA was used to confer resistance to 
RNase. Samples were then analyzed by agarose gel electrophoresis and ethidium 
bromide staining. As shown in Figure 3.12, the NP variants retained their affinities 
to the RNA. 
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Figure 3.12 Gel-shift assay of the RNA-binding activities of the defective NP 
mutants. Purified NP was incubated with a 24-nt RNA and the complexes were 
analyzed by agarose gel electrophoresis. Bovine serum albumin instead of NP was 
used as a negative control. 
Since gel shift assay is not sensitive and the amount of protein used might have 
already been in saturation, surface plasmon resonance {SPR) was employed to 
provide a more quantitative estimation of the protein-RNA binding affinity (Figure 
3.13, Table 3.1). As shown in Table 3.1, the affinity between the variant NP and 
RNA remained in sub-micromolar level. Interestingly, the Ko values may be 
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categorized into two groups - one similar to the wild-type NP-RNA and another 
about 20-60 times higher. The discrepancy is probably attributed by the different 
in vitro oligomeric state during the SPR experiment. The more oligomeric variants 
(WT, I406S, R422A, E449A) have the more RNA binding sites and thus contribute to a 
higher association rate and a higher affinity (Table 3.1). On the other hand, these 
differences in affinities to RNA did not correlate with their RNP activities. For 
example, the affinities of some fully active NP variants were significantly lower than 
the wild-type NP but similar to those partially active and inactive variants. We 
therefore conclude that the variation in RNA affinities as detected by SPR is probably 
not crucial for the RNP activity. As illustrated below, we found that the RNP 
activity is instead related to the oligomerization state ofthe protein. 
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Figure 3.13 Surface plasmon resonance of different NP variants. A concentration 
series of different NP variants were passed through the 24-nt RNA coupled SA 

























































































































































































































































































































































































































































































































To investigate their interaction with the viral polymerase, NP mutants were 
co-expressed with PB1, PB2 and myc-tagged PA in 293T 
cells. Co-immunoprecipitation was performed using anti-myc antibodies at 48 
hours post-transfection. Samples were analyzed on SDS-PAGE, followed by 
western blotting (Figure 3.14). Absence of NP in the negative control, lacking 
myc-tagged PA, indicated that NP alone was not co-immunoprecipitated by the 
anti-myc antibodies. NP was also not detected if anti-myc antibodies were not 
present during co-immunoprecipitation, demonstrating that NP and NP-polymerase 
complex did not associate with the protein-A beads themselves. In contrast, 
wild-type NP was co-immunoprecipitated in the presence of myc-tagged PA and 
anti-myc antibodies. In addition, all NP variants were shown to be 
co-immunoprecipitated with the myc-tagged polymerase complex demonstrating 
that they were able to associate with the RNA polymerase. 
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Figure 3.14 Co-immunoprecipitation of NP using myc-tagged polymerase complex. 
Wild-type NP was used as a positive control. Myc-tagged PA plasmid was left out 
in the negative control. Loading controls are shown at the upper panel. For each 
mutant, "+" refers to the presence of anti-myc antibodies while "-" refers to its 
absence. 
3.2.5 Defective NP variants possess abnormal oligomeric states in 
vitro 
We then further tested the oligomerization state of the variants by static light 
scattering. The purified NP variants were passed through a gel filtration column, a 
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light scattering detector and a refractive interferometer. The oligomeric state of 
the proteins was revealed by the calculated native molecular weight. The proteins 
were treated with RNaseA during the purification process. Wild-type NP appeared 
as a mixture of trimers and tetramers, which is consistent with our previous study 
(Ng et al” 2008). All of the eight defective NP variants show aberrant oligomeric 
states when compared with the wild-type NP (Figure 3.15), suggesting that NP-NP 
homo-oligomerization plays a significant role in the transcription-replication 
process ofthe virus. 
NP variants E339A, R416A, [V408S,P410S] and [L418S,P419S] showed almost 
undetectable levels of transcription-replication activity (Figure 3.4). Static light 
scattering of these four variants revealed that they were monomeric (Figure 3.15A), 
with a single symmetric peak at around 50 kDa. These four variants completely 
lost their oligomerization ability in vitro, which is consistent to their total loss of 
activity in the RNP assay. 
The remaining four NP variants, R267A, I406S, R422A and E449A, showed 
detectable but reduced transcription-replication activity (Figure 3.4). The latter 
three were eluted in a skewed and broad peak during static light scattering (Figure 
3.15B). The peaks were of higher molecular weight than the wild-type NP. The 
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broad peak also suggests they are a mixture of different types of oligomers. It is 
conceivable that some of the oligomeric forms are non-productive for the RNP 
activity. 
Although R267A retained 45 % of RNP activity (Figure 3.5), surprisingly it appeared 
as a single monomeric peak in static light scattering (Figure 3.15C). This 
discrepancy is most likely due to differences between the in vitro and in vivo 
conditions. To mimic the in vivo situation, we synthesized a 1850-nt long RNA by in 
vitro transcription. The RNA was mixed with the R267A NP mutant, and subjected 
to static light scattering again. An extra peak of higher molecular weight appeared, 
which resembled the profile of wild-type NP. This was not observed for those 
mutants with undetectable RNP activity (data not shown). This suggests that the 
R267A variant was able to form NP homo-oligomers upon RNA binding which could 
explain the RNP activity observed in vivo. 
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Figure 3.15 Static light scattering analysis of purified NP variants. Wild-type or 
mutant NP proteins were subject to static light scattering analysis using a 
miniDAWN triangle light-scattering detector. Light scattering signal (LS) and 
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refractive index (RI) were measured during the experiment. Curves are the light 
scattering signal. Horizontal lines are the calculated native molecular weights of 
protein, which are proportional to the ratio of LS to Rl. (A) NP variants totally 
defective in RNP activity are monomeric while wild-type NP exists as a mixture of 
trimers and tetramers. {B) Partially defective NP variants (I406S, R422A and 
E449A) gave a skewed and broad peak, and higher native molecular weights than 
wild-type NP, indicating that they exist as a mixture of different types of oligomers. 
(C) R267A exists as monomer in the absence of RNA. Addition of 1850-nt RNA to 
both wild-type and R267A lead to a high molecular weight peak on the left, 
suggesting the formation of NP-RNA complexes. Errors of native molecular weight 
were calculated from the percentage error of the experiments. 
3.2.6 NP variants with impaired RNP activity cannot form 
homo-oligomers in vivo 
We found that the four NP mutants with undetectable RNP activity (E339A, R416A, 
[V408S,P410S] and [L418S,P419S]) were unable to form oligomers in vitro (Figures 
3.4 and 3.15A). We were also interested to determine whether they behave 
similarly in vivo. Therefore C-terminal myc-tagged NP-WT, E339A, R416A, 
[V408S,P410S] and [L418S,P419S] were constructed. Each of these plasmids was 
co-transfected with their untagged counterparts into 293T 
cells. Co-immunoprecipitation was performed using anti-myc antibodies. NP was 
detected by anti-NP antibodies. Since the tagged and untagged proteins have 
distinct molecular weights and can be separated in SDS-PAGE, the presence of 
untagged NP indicates the homo-oligomerization of NP. 
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The amount of plasmid used was optimized so that the expression level of 
individual proteins was similar (Figure 3.16A). Co-transfection of myc-NP-WT and 
NP-WT was used as a positive control. The presence of the untagged NP indicates 
that co-immunoprecipitat1on was successful. Transfection of NP-WT without 
myc-NP-WT was used as the negative control. No untagged NP was observed if 
myc-NP-WT was omitted. All four untagged NP variants were detected in the 
western blot (Figure 3.16B), showing that they were co-immunoprecipitated by 
their myc-tagged counterparts. It appears that these four NP variants have the 
ability to form oligomers in vivo. However, NP is an RNA-binding protein {Compans 
et al., 1972; Scholtissek and Becht, 1971) and the observed NP-NP interaction could 
therefore have been facilitated by the presence of RNA rather than by the tail loop 
insertion. 
A previous report concluded that removal of RNA did not alter the oligomeric state 
t 
of NP (Ruigrok and Baudin, 1995). Therefore, RNaseA was added into the 
co-immunoprecipitation experiment. If the observed interaction between 
myc-tagged and untagged NP variants was due to the tail loop insertion, then 
RNaseA treatment would not disrupt the binding. On the other hand, if the 
interaction was mediated by RNA, the band of untagged NP should 
disappear. Wild-type NP was still co-immunoprecipitated with myc-tagged 
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wild-type NP after RNaseA treatment, with the band intensity similar to the 
untreated one (Figure 3.16B). This demonstrated that tail loop-mediated NP 
homo-oligomerization is not affected by the removal of RNA. The untagged NP 
bands of E339A and R416A had reduced intensity but were still detectable, 
suggesting that their tail loops were largely impaired and could not form 
homo-oligomers efficiently. The number of oligomers formed may be below the 
level of detection in the static light scattering experiment (Figure 3.15A). The 
lower bands of [V408S,P410S] and [L418S,P419S] were barely detectable or totally 
absent (Figure 3.16B, lower panel), suggesting that the previously observed 
interaction (Figure 3.16B, upper panel) was due to the presence of RNA, and 
further implying that their tail loops are defective in forming oligomers, which also 
correlates with their monomeric nature in vitro (Figure 3.15A). 
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Figure 3.16 Inability of NP mutants defective in RNP activity to form 
homo-oligomers in vivo. {A) Plasmids expressing untagged NP and C-terminal 
myc-tagged NP of the respective mutants were transfected into 293T cells. Cell 
lysates were analyzed by western blotting using polyclonal anti-NP antibodies after 
48 hours incubation. The negative control contained untagged wild-type NP alone. 
(B) Co-immunoprecipitation of untagged NP variants with their corresponding 
myc-tagged NP in the presence or absence of RNA. RNase A was used to remove 
RNA during the co-immunoprecipitation. For each variant, "+" refers to the 
presence of anti-myc antibodies while "-" refers to its absence. 
3,3 Discussion 
The recent pandemic outbreak of A/H1N1 swine influenza has highlighted the fact 
that the number of inhibitors available against influenza virus is limited and further 
antivirals are required. Among the influenza viral proteins, NP is crucial for 
encapsidat1ng RNA and the transcription-replication process (Ng et al., 2009; Shu et 
al., 1993). In addition, it is highly conserved and therefore it is an attractive 
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candidate for inhibitor design {Krug and Aramini, 2009). 
Determination of the H1N1 and H5N1 NP crystal structures has revealed the 
importance of tail loop insertion in NP homo-oligomerization (Ng et al., 2008; Ye et 
al., 2006). In contrast to the NP structures of rabies virus {Albertini et al.,2006) and 
vesicular stomatitis virus (Green et al” 2006), the tail loop of each influenza A virus 
NP is deeply inserted into the groove of its neighboring NP, generating extensive 
interactions between the two proteins. 
The inter-subunit interaction between the tail loop and the insertion groove is 
mediated solely by salt bridges. Hydrogen bonds between E339 and R416 at the 
tip region (Cluster II) play a critical role in this event. Mutation of R416A totally 
abolished RNP activity (Figure 3.4), which is consistent with the previous findings by 
other groups (Coloma et al., 2009; Elton et al., 1999; Li et al., 2009). Mutation of 
E339A also leads to the complete loss of the RNP activity (Figure 3.4). Both E339A 
and R416A mutants were found to be monomeric in vitro (Figure 3.15A)； similar to 
the previous findings by gel filtration analysis (Ye et al., 2006). These two mutants 
also formed mainly monomers in vivo, in the absence of RNA (Figure 3.166, lower 
panel). Since the tail loop conformation of the E339A and R416A mutants was not 
disrupted, their tail loops may still be able to gain access to the groove although 
99 
this interaction is not maintained, hence giving rise to the small degree of 
interaction observed (Figure 3.16B, lower panel). The similar behavior of these 
two protein mutants strengthens the conclusion about the importance of this 
ion-pair. Analysis of 2500 influenza A NP sequences also reveals that both residues 
are strictly conserved (Table 3.2). Sequence alignment shows that both residues in 
influenza A NP are identical to the corresponding residues in influenza B and C NP 
(Table 3.2). This further supports the functional importance of such an interaction, 
and implies that the interaction is conserved throughout all influenza NP 
proteins. In addition to cluster II, cluster 13 which is located at the stem region, 
also exerts a supportive role in the inter-subunit interaction. Mutation of R267A, 
the central residue of cluster 13, resulted in a reduction in RNP activity (Figure 
3.4). R267A also lost its ability to form oligomers in vitro, which was restored in 
the presence of RNA (Figure 3.15C). Mutations at clusters 12 and 14 did not show 
significant reductions in RNP activity, and therefore are unlikely to be important for 
NP homo-oligomerization. 
In contrast to inter-subunit interactions, the tail loop conformation of NP is 
maintained mainly through hydrophobic interactions at the stem region. Four 
non-polar residues, V408, P410, L418 and P419 (cluster T2), form a zig-zag pattern 
of interaction. Double point mutants [V408S,P410S] and [L418S,P419S] showed no 
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detectable RNP activity (Figure 3.4). Both protein variants were monomeric in 
vitro (Figure 3.15A) and in vivo (Figure 3.16B, lower panel) in the absence of 
RNA. Interestingly, single point mutants of these four non-polar residues all 
showed wild type RNP activity. This suggests a 'back-up' mechanism of tail loop 
maintenance. Normal RNP activities of V408S and L418S (Figure 3.4) indicate that 
either of P410-L418 or V408-P419 interaction is sufficient for conformational 
maintenance of the tail loop. The presence of two pairs of non-polar residues 
could maintain tail loop conformation and possibly sustain virus survival even if one 
of the four residues is mutated. This is also observed naturally as V408 is 
polymorphic (can be either I or T) in influenza A NP, although the other three 
residues remain conserved (Table 3.2). Influenza B NP may also use hydrophobic 
interactions to maintain the stem of the tail loop, but without the back-up 
mechanism. P410 is identical while L418 is replaced with an I in influenza B 
NP. The P410-I418 interaction is conserved in influenza B NP and one hydrophobic 
interaction might be adequate for tail loop maintenance. However, the 
corresponding hydrophobic residues are not present in influenza C NP, suggesting 
that it may use another mechanism for such tail loop maintenance. Cluster T1 
appears to play a role in tail loop maintenance, as mutation of R416A abolished the 
RNP activity (Figure 3.4). However, R416 also takes part in cluster 11 for 
inter-subunit interaction. Since double point mutants [V408S,P410S] and 
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[L418S,P419S] showed no detectable RNP activity in the presence of R416, R416 by 
itself is not sufficient to maintain the tail loop conformation. 
In addition to the inter-subunit interaction and tail loop maintenance, stabilization 
of the NP homo-oligomer is necessary for a fully functional RNP. Stabilizing power 
is contributed by the base region. The tail loop itself is stabilized by cluster T3, 
centered at 1406 while the inter-subunit interaction is stabilized by cluster 15, with 
the R422-E449 ion pair. Protein variants of I406S, R422A and E449A all displayed 
abnormal oligomeric states in static light scattering (Figure 3.15B). Abnormal 
oligomerization is likely to result in the reduction of RNP activity (Figure 
3.4). Although 1406 is polymorphic in influenza A NP (can be either V or T), the 
corresponding residue in influenza B and C NP is identical, further suggesting the 
functional importance of this residue. The R422-E449 interaction is also partially 
conserved in influenza B and C NP (Table 3.2). This ion pair has been previously 
reported as the molecular contact for trimerizati'on {Ng et al., 2008), hence implying 
that the mode of interaction of trimeric NP in the crystal structure and the 
oligomeric NP inside cells is highly similar. 
102 
TABLE 3.2: Variability of residues important for NP homo-oligomerization 
Influenza A NP Influenza B NP Influenza C NP 
Position Residue Position Residue Position Residue 
267 R 325 R 272 K 
339 E 395 E 354 E 
406 I 462 I 416 I 
408 l/V 464 C 418 N 
410 P 466 P 420 A 
416 R 472 R 426 R 
418 L 474 I 428 I 
419 P 475 A 429 T 
422 R/K 478 K 432 V 
449 E 505 N 459 E 
Corresponding residues of each type of NP are listed in row. Conserved residues are 
shown in bold letters. 
In conclusion, we have identified three factors which govern the NP 
homo-oligomerization event: (1) interaction between the tail loop and the insertion 
groove; (2) maintenance of the tail loop conformation; and (3) stabilization of NP 
homo-oligomer. The first two factors are crucial for NP-NP interaction as well as 
the transcription-replication activity of the viral RNP. The third factor plays a minor 
but supportive role in the process； since destabilizing the homo-oligomer results in 
reduced but not totally abolished RNP activity. In general, the tip and the stem 
regions of the tail loop are more important than the base region. 
The data presented in this report also gives insights towards the sequential events 
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of the tail loop insertion process. First； it is essential for the tail loop to maintain a 
proper conformation. Disruption of the conformation by [V408S,P410S] or 
[L418S;P419S] led to a greatly reduced interaction in the co-immunoprecipitation 
study (Figure 3.16B, lower panel) possibly because the disrupted tail loop could not 
access the insertion groove. Second, the inter-subunit interactions between the 
tail loop and the insertion groove are crucial. Mutations at R416A and E339A did 
not affect tail loop conformation and therefore could access the insertion groove; 
nevertheless they resulted in minimal NP-NP interaction (Figure 3.16B) and 
possessed no detectable RNP activities due to the inability of inter-subunit 
interaction. Third, the NP homo-oligomer is further stabilized by intra- and 
inter-subunit interaction of clusters T3 and 15 at the base of the tail loop. 
We have identified the E339-R416 ion pair and the hydrophobic interactions 
between V408, P410, L418 and P419 as the essential molecular contacts for the NP 
homo-oligomerization process. Based on these findings, inhibitors that can disrupt 
either the ion pair or the hydrophobic interactions, and therefore disrupt NP 
homo-oligomerization, should restrict the transcription-replication processes ofthe 
virus. Such antiviral drugs would inhibit influenza virus and could relieve the 
symptoms of influenza in patients. This strategy could be used in the future to 
design novel influenza virus inhibitors. 
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Chapter 4 
Biophysical characterization of the interaction between influenza nucleoprotein 
and importin a 
4,1 Introduction 
The influenza virus genome consists of eight segmented, negative stranded RNA 
which associate with four viral proteins to form ribonucleoprotein particles (RNPs) 
(Murt1 et al., 1988). It is one of very few RNA viruses to replicate in the nucleus with 
the use of cellular splicing machinery to facilitate the complete replication cycle 
(Boulo et al., 2007). After cell entry, the RNPs are released from the viral matrix 
protein under low pH of the endosome and are actively imported into the nucleus 
(Bui et al., 1996). The proteins essential for the assembly of new RNPs are translated 
in the cytoplasm and imported into the nucleus. Newly made matrix protein, 
nuclear export protein (NEP) and NS1 are also imported into the nucleus. Nuclear 
export of the newly assembled RNPs is mediated by the interaction between RNP 
and matrix protein and between matrix protein and NEP (Bui et al., 2000; Neumann 
et al., 2000; O'Neill et al., 1998). NEP contains the nuclear export signal for transport 
ofthe RNPs to the cytoplasm (O'Neill et al., 1998). New virus particles are generated 
by budding off underneath the cell surface. There appears to be an intricate ballet in 
exposing and hiding nuclear transport signals which leads to a unidirectional 
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transport of the RNPs to the nucleus at the start of the infection process and an 
opposite unidirectional export of RNPs at the end ofthe infection. 
Ions and proteins with molecular weights of less than about 40kDa can enter the 
nucleus freely by diffusion through the nuclear pore complex {NPC). Import of larger 
protein is an active process which requires the interaction with transporter 
molecules—importins (lmamoto et al., 1995). lmportins are categorized into two 
types, a and p. Importin a recognizes the nuclear localization signal (NLS) on the 
cargo proteins. Once the cargo is bound by importin a, the complex is recognized 
and bound by importin p which subsequently binds to the fibrils of the NPC for the 
translocation (Bayliss et al., 2000). A single importin |3 can recognize different 
importin a isoforms that contain specificity toward different variants of NLSs (Conti 
et al., 2006). Importin a consists of a flexible N-terminal importin-P-binding (IBB) 
domain and a highly structured tandem armadillo (ARM) repeats (Cingolani et al., 
1999; Conti et al., 1998). The IBB domain contains an autoinhibitory sequence that 
interacts either in trans with importin p or in cis with the NLS-binding groove built of 
the repeats (Herold et al., 1998). These interactions allow the IBB domain to act as a 
competitive inhibitor to regulate binding of NLS cargo to the binding groove. 
NLS motifs consist of several positively charged amino acids (Arg and Lys) and are 
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typified by either a single cluster of basic residues (monopartite) or two clusters of 
basic residues separated by a 10-12 amino acid linker (bipartite) (Hodel et al., 2001). 
At least two NLSs have been identified on NP: a non-conventional NLS at the very 
N-terminal 13 residues of the molecule {NLS1) (Wang et al., 1997) and a classical 
bipartite signal between residues 198-216 {NLS2) (Weber et al., 1998). Previous 
findings revealed the relative contributions of the two NLSs during the replicative 
cycle of the virus. NLS1 is critical for nuclear import of NP and RNP, but is not 
essential for viral replication. On the other hand； the contribution of NLS2 to nuclear 
transport of NP is limited, but is essential for vRNA transcription and the nucleolar 
accumulation of NP for allowing virus replication (Ozawa et al., 2007). To combat 
this ever-changing disease, the use of single drug treatment may no longer be 
effective while a cocktail or combination therapy is now proposing (6eigel and Bray, 
2008). In this study, we aim at identifying which NLS to target on using a biophysical 
approach in order to prepare for the latter in-silico drug design. 
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4.2 Results 
4.2.1 Expression and Purification ofNP-WT/NLS variants and importin 
a 
Expression and purification of NP wildtype and its NLS variants were similar to those 
of NP defective oligo-variants as described in 3.2.3. NP-ANLS1 (aal-13 deleted); 
NP-NLS2mut (R213A, K214A and R216A) (Cros et al., 2005) and double mutant 
NP-ANLSl;NLS2mut were also expressed and purified. 
4.2.1.1 Expression ofHis-taaaed imoortin al. 3 ancl5 
Recombinant His-tagged importin otl, 3 and 5 were expressed in E. coli strain 
BL21(DE3)pLysS in M9ZB medium at 30 °C for 16 hours. The molecular weight of 
the three His-tagged importin a was estimated to be around 50 kDa by the program 
PortParam. The cells were harvested and proteins were released by sonication. 
The supernatant, pellet and whole lysate of His-tagged importin a5 were analyzed 
by SDS-PAGE (Figure 4.1). Most His-tagged importin a5 was found to be present in 
the supernatant portion. The expression levels of importin a l and 3 were found to 
be similar (data not shown). 
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Figure 4.1 Expression of His-tagged importin a5. The target protein was 
expressed in M9ZB medium at 30 °C for 16 hours. A large proportion of the 
His-tagged- importin a5 was found in the supernatant 
4.2.1.2 Purification ofimportin al. 3 and 5 
4.2.1.2.1 Metal Chelating IMAC affinity chromatography 
His-tagged importin a5-containing soluble fraction of the cell lysate was applied to 
an affinity column, metal chelating IMAC. His-tagged importin a5 was eluted by a 
0-100 % of l M imidazole gradient. The elution profile is shown in Figure 4.2. 
Eluted fractions were collected and analyzed by SDS-PAGE (Figure 4.3). Importin 
a5 was mainly eluted from fractions 31 to 33 (4 ml/fraction) and these fractions 
were concentrated and exchanged with gel filtration buffer. Importin a l and 3 were 
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Figure 4.2 Elution profile of Importin a5 by metal chelating IMAC column 
chromatography. Proteins were eluted by a 0-100 % of l M imidazole gradient. 
Importin a5 was eluted from fractions 31-33, with 4 ml/fraction. Non-specific 
binding was found from fractions 19 to 30. 
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Figure 4.3 SDS-PAGE of metal chelating IMAC column chromatography. Eluted 
fractions were analyzed. Importin a5 was mainly eluted from fractions 31 to 33. 
Fractions 25 and 26 from non-specific binding (fractions 19 to 30) were found to 
have trace amount of Importin a5. 
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4.2.1.2.2 Gel filtration chromatography 
The concentrated fractions were injected into a Superdex™ 75 gel filtration column. 
Importin a5 was eluted early, just after the breakthrough of the column. The 
elution profile is shown in Figure 4.4. Eluted fractions were collected and analyzed 
by SDS-PAGE (Figure 4.5). Importin a5 was mainly eluted from fractions 17 to 26 (2 
ml/fract1on). Importin a l and 3 were purified according to the above protocol 
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Figure 4.4 Elution profile of Importin a5 by gel filtration column chromatography. 
Proteins were eluted by a steady flow of 20 mM Tris-HCl, 200 mM NaCI, 2mM DTT, 
pH 8.0. Importin a5 was eluted just after the breakthrough of the column, from 
fractions 13-33, with 2 ml/fraction. 
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Figure 4.5 SDS-PAGE of gel filtration column chromatography. Eluted fractions were 
analyzed. Importin a5 was mainly eluted from fractions 17 to 26. 
4.2.1.3 NP-WT/NLS variants and imoortin awere ourified to hiah homoaeneitv 
After purification by column chromatography, the purity of NP-WT, NP-NLS2mut, 
NP-ANLS1, NP-ANLSl;NLS2mut, importin a l , importin a3 and importin a5 were 
assessed by SDS-PAGE (Figure 4.6). The proteins were found to attain a high 
homogeneity. 
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Figure 4.6 SDS-PAGE of all purified proteins: NP-WT, NP-NLS2mut, NP-ANLS1, 
NP-ANLSl;NLS2mut, importin a l , importin a3 and importin a5. 
4.2.2 Pull down Assay 
Importin a l , 3 and 5 were successfully immobilized onto three respective 1 ml NHS 
columns. Purified NP-WT was passed through the three respective columns and 
column without importin (Control). Bound proteins were eluted by 1 M NaCl. 
Fractions of washing and elution were analyzed by SDS-PAGE (Figure 4.7). 
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Figure 4.7 In vitro pull down assay on NP suggesting NP interacts with importin a l , 
3 and 5. NP-WT was loaded to NHS-Sepharose pre-coated with importin a l , 3 and 
5 respectively. Bound protein was eluted with 1 M sodium chloride. The column 
was washed to get rid of all non-specific binding. The last washing fraction (Wash) 
and bound protein collected during elution (Elute) were analyzed by SDS-PAGE. NP 
binds strongly to importin a l and importin a5 (a and c), while weakly to importin 
oc3 (b). Control experiment showed that NP did not bind Sepharose (d). 
4.2.3 Light scattering analysis (NP-lmportin a5) 
Static light scattering analysis was performed to determine the binding ratio 
between importin a5 and RNaseA-treated NP-WT (Figure 4.8). RNaseA-treated 
NP-WT was found to have molecular weight around 193kDa, indicating that NP-WT 
existed in a mixture of trimers and tetramers. The molecular weight of importin a5 
and NP-WT—importin a5 complex were found to be 53kDa and 249kDa respectively. 
Therefore, it was suggested one NP trimer/ tetramer binds to one importin a5. 
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Figure 4.8 (A) Light scattering of NP-WT, importin a5 and NP-WT—importin a5 
complex. The light scattering signal of NP-WT (blue), importin a5 (red) and 
NP-WT—importin ot5 complex (green) was plotted against elution volume. (B) 
SDS-PAGE of eluted fractions corresponding to the respective peak. Two bands 
corresponding to NP monomer and importin a5 were observed from the peak of 
NP-importin a5 interaction while only one band of NP monomer or importin a5 can 
be seen from their respective peak. 
4.2.4 Binding assay of NP NLS variants with importin a5 
4.2.4.1 Co-Durification ofNP NLS variants and imoortin a5 from E.coH 
To assess the importance of the two NLSs on NP on binding to importin a5, a 
co-purification assay using E. coli as model was performed. NP plasmid DNA was 
co-transformed with importin a5 to BL21{DE3)pLysS. Colony was selected to grow in 
5 ml culture and was allowed to express protein under 30 °C for 16 hours after the 
addition of IPTG. Cell lysate was incubated with amylose beads where MBP-NP binds 
to. Proteins were eluted with maltose. As shown in Figure 4.9, MBP-NP (WT, ANLS1, 
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NLS2mut; ANLSl;NLS2mut) was co-expressed with importin a5. All MBP-NP variants 
were eluted but with a5 accompanying WT and NLS2mut NP only, indicating that 
removal of NLS1 perturbs the interaction of NP and a5. This suggests the dominant 
role of NLS1 over NLS2 in binding to importin a5. 
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Figure 4.9 Co-purification of NP NLS variants and importin a5. The lysate 
contained over-expressed MBP-NP and His-tagged importin a5 (L). Eluent (E) 
contained MBP-NP of around lOOkDa. Importin a5 of 56kDa appeared with wild 
type and NLS2mut NP, but not with ANLS1 and ANLSl;NLS2mut NP. 
4.2.4.2 Co-immunopreciDitation ofNP NLS variants and imoortin a5 
To investigate if differences occur between E.coli and mammalian system, 
myc-tagged NP NLS mutants were co-expressed with Flag-tagged full-length 
importin a5 in 293T cells. Co-immunoprecipitation was performed using anti-myc 
antibodies at 48 hours post-transfection. Samples were analyzed on SDS-PAGE, 
116 
followed by western blotting (Figure 4.10). Absence of importin ot5 in the negative 
control, lacking myc-tagged NP, indicated that a5 alone was not 
co-immunoprecipitated by the anti-myc antibodies. Importin a5 was also not 
detected if anti-myc antibodies were not present during co-immunoprecipitation, 
demonstrating that a5 and NP-a5 complex did not associate with the protein-A 
beads themselves. In contrast, importin a5 was co-immunoprecipitated in the 
presence of myc-tagged wild type NP and NLS2mut, but not with ANLS1 and 




i / i ^ 
丄 / / / 身 
^ t t ^ ^ i ^ ^ L ^ t ' : : ' ' ' 
^ ^ ^ ^ 攀 ― 一 _ 一 - 5 
一 - 〜 一 . 
^ V H H I H H | ^ < •• NPWT/variants 
^^WWBm -
/ 
/ / / 
^ “ / / / 身 
WB:a-Flag ^ ^ ^ s i ^ ^ l l f e — F.ag-tagged..portina5 
講 : 《 - 丨 零 隱 ' 義 . � • • ' / - ^ ^ ^ < - N P W T / v a r i a n t s 
Figure 4.10 Co-immunoprecipitation of importin a5 using myc-tagged NP 
Wildtype NP was used as a positive control. Myc-tagged NP plasmid was left out in 
the negative control. Loading controls are shown at the upper panel. For each 
mutant, "+" refers to the presence of anti-myc antibodies while "-" refers to its 
absence. 
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4.2.5 BIAcore 3000 Surface Plasmon Resonance (NP-lmportin a5) 
To further characterize the interaction between NP and importin a5, BIAcore 3000 
surface plasmon resonance was performed to determine different biophysical 
constants. Importin a5 was first immobilized to a level of 428 Response Unit (RU) 
on a CM5 sensor clip. An increasing amount of NP or its variants including 
NP-ANLS1, NP-NLS2mut, NP-ANLSl;NLS2mut were individually allowed to pass 
through the chip surface (Figure 4.11). No mass transfer effect was observed from 
the control experiment (data not shown). From the result, it was found that 
NP-ANLS1 had a closer affinity as wild-type NP and a much higher affinity than 
NP-NLS2mut when interacting with importin a5, indicating that NLS2 bind stronger 
than NLS1 to importin a5. A graph showing the relative binding curves of NP and 
its variants, and the control (BSA and buffer alone) was plotted (Figure 4.12). 
Different biophysical parameters including association constant, dissociation 
constant and binding affinity of the interaction between importin a5 and NP-WT/ 
NLS variants were calculated using the fitting of 1:1 binding with drifting baseline 
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Figure 4.11 - Sensogram of the binding of wild-type NP and its variants to 
immobilized importin a5. Different concentration of purified (a) NP-WT, (b) 
NP-ANLS1, (c) NP-NLS2mut and (d) NP-ANLS1; NLS2mut were injected and the signal 
(RU) was plotted as a function of time. The square boxes (•) represent the averages 
from three independent experiments while the solid lines {-) represent the fitted 
curves. 
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Figure 4.12 - The relative binding curves of NP and its variants toward importin a5. 
Wild-type and variant NPs (25 nM) were allowed to bind to immobilized importin a5. 











































































































































































































































































































































































































































































































































4.2.6 QRT-PCR (NP-lmportin a5) 
To find the effects of the two NLSs on RNP activity； myc-tagged wild type NP and its 
NLS mutants were individually co-transfected with plasmids expressing polymerase 
proteins and a reporter plasmid (NA). At 48 hours post-transfection RNA was 
extracted and QRT-PCR was used to analyze the level of NA mRNA. Using wild type 
NP as a 100% RNP activity control, ANLS1 retained around 70% RNP activity, while 
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Figure 4.13 QRT-PCR analysis of vRNA transcription. Different myc-tagged NP 
plasmids were mixed with pcDNA-PBl, pcDNA-PB2, pcDNA-PA and pPOU-NA-RT 
and transfected into 293T cells. RNA was isolated after 48 hours incubation and 
analyzed by QRT-PCR. RNA levels for each NP NLS mutant were compared to 
wild-type NP which was set to 100%. The results represent the mean percentage 土 
standard deviation from three independent experiments (*p=0.05; **p=0.0005). 
A control experiment was performed to verify if myc-tagged wild type NP and its 
variants interact with polymerase. Myc-tagged wild type NP and its NLS mutants 
were individually co-transfected with plasmids expressing polymerase proteins, a 
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reporter plasmid (NA) and Flag-tagged importin a5 to 293T cells. 
Co-immunoprecipitation was performed using anti-Flag antibodies at 48 hours 
post-transfection. Samples were analyzed on SDS-PAGE, followed by western 
blotting (Figure 4.14). In the negative control which lacked Flag-tagged a5, absence 
of myc-tagged wild type NP indicated that NP alone was not co-immunoprecipitated 
by the anti-Flag antibodies. NP was also not detected if anti-Flag antibodies were 
not present during co-immunoprecipitation, demonstrating that NP and NP-a5 
complex did not associate with the protein-A beads themselves. In contrast, 
myc-tagged wildtype NP and all its variants were co-immunoprecipitated in the 
presence of Flag-tagged a5. Compared with the previous result which showed that 
when polymerase subunits were absent, NP-ANLS1 and NP-ANLS1; NLS2mut were 
unable to bind to a5 (Figure 4.10). This demonstrated the depletion of RNP activity 
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Figure 4.14 Co-immunoprecipitation of importin a5 and RNP. Wildtype NP was 
used as a positive control. Flag-tagged importin a5 plasmid was left out in the 
negative control. Loading controls are shown at the upper panel. For each 
mutant, "+" refers to the presence of anti-Flag antibodies while "-" refers to its 
absence. 
43 Discussion 
The viral NP and the cellular importin a are two important proteins for the 
replication cycle of influenza virus, especially in mediating the nucleocytoplasmic 
trafficking of RNP complex. It was reported that NP binds to a number of human 
importin a (a l , a3 and a5) both in vivo and in vitro (O'Neill and Palese 1995; Wang 
et al., 1997; Melen et al., 2003). Since NP is relatively conserved among various 
influenza A viruses, further studies of NP intracellular transport would both help 
designing appropriate inhibitors and improving our understanding of protein 
transport. 
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The presence of two or more Nuclear Localization Signals (NLSs) is a common 
feature of many cellular and viral proteins targeted for the nucleus. In some 
instances, multiple NLSs seem to cooperate to enhance nuclear import (Ylikomi et 
al., 1992), whereas in others they act independently (Nadler et al., 1997). A 
unique property of influenza viruses among RNA viruses is that every step of vRNA 
synthesis takes place in the nucleus by using the nuclear machinery ofthe host cells. 
Therefore, newly synthesized proteins required for the vRNPs and its export must 
be transported into the nuclei of the cells (Lamb and Krug, 1996). NP contains two 
NLSs, namely NLS1 and NLS2. Their relative contribution in mediating the nuclear 
import and viral replication was intensively studied. Based on these, a follow-up 
biophysical study can help determine the NLSs on NP that may be a better site for 
future in-silico drug screening. 
The design of NLS-inactivated NP variants was based on the previous findings on 
the two NLSs on NP. Residues 1-13 were identified as an unconventional 
monopartite NLS (NLS1) by yeast two-hybrid system (Wang et al., 1997), while 
residues 198-216 were later identified as a classical bipartite NLS (NLS2) by 
promoting nuclear localization of a cytosolic reporter protein after conjugating with 
the NLS2 peptide (Weber et al , 1998). Crystal structure of NP showed that the 
electron density was disordered at the NLS1 region (Ng et al., 2008), probably due 
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to the high flexibility of NLS1. Also, successful inactivati'on of NLS2 by mutating its 
critical amino acid residues was reported (Cros et al., 2005). Based on these two 
rationales, NP variants including aal-13 deleted NP {NP-ANLS1); R213A, K214A and 
R216A mutated NP (NP-NLS2mut) and the double mutant (NP-ANLS1; NLS2mut) 
were designed and cloned. 
The DNA of NP and its mutants were cloned into pRHisMBP vector to facilitate the 
expression and purification of the fusion protein. MBP-tagged NP was highly 
soluble, expressed in high quantity and could be easily purified by amylose column. 
The proteins could be fully digested by thrombin into MBP and NP, suggesting that 
MBP and NP were independently folded. The purity of NP can be further 
enhanced by heparin column, which is generally used for purifying 
nucleot1de-binding proteins. 
From the crystal structure of the full-length mammalian importin a (Kobe et al., 
1999), the NLS binding site was found to be occupied by its N-terminal 
autoinhibitory sequence. The competition between the NLS and the 
autoinhibitory sequence of importin a could make the in vitro biophysical study 
difficult. Therefore the N-terminal truncated (lacking residues 1-69) importin a l , 
3 and 5 were cloned and expressed. 
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E.coli expression system was used for both NP and importin a since these bacterial 
expressed proteins could be successful crystallized (Ye et al., 2006 and Fontes et al., 
2000). Therefore, there should be limited alternation of their native activity and 
can be subject to further biophysical assays. 
The present data of the in vitro pull down assay showed that NP binds strongly to 
importin a l and 5, but lesser extent to importin a3, in an agreement to the 
previous findings by Melen et al. (2003). Among the six human importin a 
proteins, the sequence similarity is over 60%. Mutation at arm repeat 8 of a5 
abolished the binding to NP while of the corresponding mutation on a3 did not, 
suggesting the binding mode of different importin a towards NLSs are different 
(Melen et al., 2003). Since C-terminal arm repeats of importin a l and a5 were 
found to bind both classical and nonclassical NLSs {Herold et al., 1998; Goodwin 
and Whitehouse, 2001), and in particular a5 was well characterized in 
crystallography (Kobe et al., 1999), importin a5 was chosen to be a model to study 
NP NLSs. 
Static light scattering analysis showed that one importin a5 bind to one NP trimer/ 
tetramer. Importin a is a negatively-charged protein by having pl of around 5, more 
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than one importin a binding to one NP trimer/tetramer may result in unfavorable 
interaction due to charge-charge repulsion. To further investigate the crucial 
element of NP for binding a5, binding assays and biacore SPR were performed. 
Both binding assays on NP NLS variants to importin a5 using E.coli and mammalian 
system showed that removal of NLS1 perturbed the binding of NP to a5. This 
indicates the necessary of NLS1 in nuclear import, which is consistent with the 
findings by other groups using cellular localization study {Cros et al., 2005; Ozawa et 
al., 2007; Wu and Pante, 2009). Since the accessibility of an NLS can be regulated by 
phosphorylation or structural masking (Vandromme et al” 1996), and NLS1 can be 
functionally impaired by phosphorylation on serine 3 (Bullido et al., 2000), here the 
similar results from both systems reveal post-translat1onal modification is not a 
factor in regulating the dominance of NLSs on NP in binding to a5. 
By kinetic measurement using surface plasmon resonance (SPR), the affinity 
constant Koof importin a5 and NP-WT interaction was found to be 1.81 士 0.1 x 10'^  
M. This value is comparable to the previous fluorescence study on the interaction 
between importin a and simian virus 40 (SV40) large T-antigen NLS, where their 
binding affinity was determined to be ~10 nM (Fanara et al., 2000). The higher 
affinity of NP-importin a5 interaction can be explained by the presence of two NLSs 
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on NP for binding to importin-a5, but only one was found on SV40 large T-antigen. 
Control by using BSA and buffer alone were done to ensure the result obtained was 
not due to non-specific binding. Also, no mass transfer effect was observed from 
the standard control experiment suggesting that it was a single association and 
dissociation process. 
Previous study on co-crystallization of mouse importin a with monopartite NLS 
from SV40 large T-antigen and the bipartite NLS from nucleoplasmin provided the 
structural basis about the mode of binding among the diverse NLSs to importin-a 
(Fontes et al., 2000). Nevertheless, the relative affinity of the two NLSs on NP in 
binding to different importin a isoforms was still unknown. Here, we proceed to 
find the respective binding affinity of the two NLSs on NP to importin a5 by SPR. 
When compared with NP-WT, the affinity of importin a5 to NLSs mutated NP 
decreased significantly, indicating that NLSs are important for the binding to a5. 
Surprisingly, ANLS1 NP caused ~3 folds decrease in affinity, while NLS2mut NP 
resulted in nearly 6 folds. The result here seems to be inconsistent with the binding 
assays, but it gives insight on the predominant role of NLS1 in binding to importin 
a5. Static light scattering showed NP existed as trimer/ tetramer in an RNA-free in 
vitro condition, which is in similar environment as biacore. However, both binding 
assays here and previous studies were done in vivo, where RNA was present. 
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Ultrastructural analysis showed that a number of NLSls on a RNP complex are 
highly exposed to the environment, while NLS2s may be hidden by oligomeric 
interactions either from the assembly of NP molecules or from its interaction with 
the vRNA (Wu et al.； 2007). It is conceivable that the presence of RNA can mask 
NLS2 by either triggering the oligomeric state of NP or its own binding to NP, 
allowing NLS1 to be exposed to interact with importin a5 in the binding assays. On 
the other hand, removal of RNA during the purification steps may expose both NLSs 
to bind to importin a5 in biacore SPR experiment. From the crystal structure of 
mouse importin-a with monopartite and bipartite (Fontes et al., 2000), both major 
arm and minor arm of ot5 were allowed to bind NLS. Here； NLS2, being a classical 
bipartite NLS, was able to situated both binding arm on a5, while NLS1, a 
nonclassical monopartite NLS, may be able to bind to one arm only due to steric 
hindrance by neighbouring NP protomer. Therefore, it is plausible that a relatively 
lower affinity was observed when we mutated NLS2. Recent finding showed that 
the conformationally mature NP oligomers can be imported to nucleus while 
weakly associated NP mulitmers cannot (Semenova et al., 2008). This suggested a 
conformation-induced exposure of NLSs on NP. However, the RNA-mediated 
oligomeric status of NP and its correlation to NLSs exposure remains further 
investigations. 
RNP reconstitution assay analyzed by QRT-PCR showed the RNP activity was 
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significantly abolished when NLS2 was mutated, while 70% activity was retained 
with deleted NLS1. Previous study showed that NLS1 mutation can still support 
virus replication, albeit to a limited extent. On the other hand, NLS2 was needed 
for vRNA synthesis and virus reconstitution (Ozawa et al., 2007). The consistency 
here indicates that NLS2 is important for vRNA transcription, but through an 
unknown mechanism. Recent report showed that NLS2 is masked in cytoplasm but 
exposed after entry to nucleus (Wu and Pante, 2009), suggesting NLS2 functions are 
not limited to nuclear import. 
In summary, NP was shown to bind with importin a l , 3 and 5. In particular, one 
importin a5 bind to one NP trimer/tetramer. NLS1 was found to be essential for 
importin a binding in vivo, while NLS2 on NP was found to bind stronger to importin 
a5 than NLS1 in vitro. Cellular study demonstrated that NLS2 is essential for vRNA 
transcription. Though previous work showed that nonfunctional NLS1 inhibit the 
nuclear import of RNP and NP, the degree of abolishment was still remained 
questionable. To develop drugs against NP, the biophysical assays here suggested 
the interaction of NP and importin may not be an appropriate target to work on, 
while NLS2 on its own is worth to attempt in-silico screening in the future due to its 
essential but unknown function on viral replication. Studies revealed NLS2 helps NP 
to localize at the nucleolus (Ozawa et al., 2007), but more information is still waiting 
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be provided for a better understanding on the nucelocytoplasmic trafficking. 
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